(+)-artemisinin increases expression ISO RGD:1346751 6480464 artemisinin results in increased expression of CYP2B6 mRNA CTD PMID:15761118 , PMID:18332078 (+)-artemisinin affects metabolic processing ISO RGD:1346751 6480464 CYP2B6 protein affects the metabolism of artemisinin CTD PMID:12920490 (+)-artemisinin multiple interactions ISO RGD:1346751 6480464 [artemisinin results in increased activity of NR1I3 protein alternative form] which results in increased expression of CYP2B6 mRNA CTD PMID:17041008 (+)-isoborneol multiple interactions ISO RGD:1346751 6480464 isoborneol inhibits the reaction [CYP2B6 protein results in increased hydrolysis of Bupropion] CTD PMID:18611395 (+)-Nornicotine increases chemical synthesis ISO RGD:1346751 6480464 CYP2B6 protein results in increased chemical synthesis of nornicotine CTD PMID:30906561 (+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of CYP2B3 mRNA] CTD PMID:31150632 (-)-anisomycin multiple interactions ISO RGD:1346751 6480464 [6-(4-chlorophenyl)imidazo(2 more ... CTD PMID:23539296 (-)-cotinine increases chemical synthesis ISO RGD:1346751 6480464 CYP2B6 protein results in increased chemical synthesis of Cotinine CTD PMID:12488541 (-)-selegiline decreases activity ISO RGD:1346751 6480464 Selegiline results in decreased activity of CYP2B6 protein CTD PMID:25656918 (-)-selegiline multiple interactions ISO RGD:1346751 6480464 Selegiline inhibits the reaction [CYP2B6 protein results in increased hydroxylation of Bupropion] CTD PMID:25656918 (-)-trans-epsilon-viniferin decreases activity ISO RGD:1346751 6480464 epsilon-viniferin results in decreased activity of CYP2B6 protein CTD PMID:12818727 (1->4)-beta-D-glucan multiple interactions ISO RGD:1624098 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CYP2B9 mRNA CTD PMID:36331819 (E)-roxithromycin decreases activity ISO RGD:1346751 6480464 Roxithromycin results in decreased activity of CYP2B6 protein CTD PMID:17164692 (E,E)-germacrone decreases activity ISO RGD:1346751 6480464 germacrone results in decreased activity of CYP2B6 protein CTD PMID:23850985 (E,E)-germacrone increases expression ISO RGD:1346751 6480464 germacrone results in increased expression of CYP2B6 mRNA CTD PMID:23850985 (R)-camphor multiple interactions ISO RGD:1346751 6480464 Camphor inhibits the reaction [CYP2B6 protein results in increased hydrolysis of Bupropion] CTD PMID:18611395 (R,R,R)-alpha-tocopherol decreases expression ISO RGD:1624098 6480464 alpha-Tocopherol results in decreased expression of CYP2B9 mRNA CTD PMID:26102010 (S)-nicotine increases metabolic processing ISO RGD:1346751 6480464 CYP2B6 protein results in increased metabolism of Nicotine CTD PMID:12488541 (S)-nicotine increases oxidation ISO RGD:1346751 6480464 CYP2B6 protein results in increased oxidation of Nicotine CTD PMID:30906561 (S)-nicotine affects oxidation ISO RGD:1346751 6480464 CYP2B6 gene polymorphism affects the oxidation of Nicotine CTD PMID:30906561 (S)-nicotine multiple interactions ISO RGD:1346751 6480464 CYP2B6 gene polymorphism affects the reaction [CYP2A6 protein results in increased metabolism of Nicotine] CTD PMID:18004205 1,1,1-Trichloro-2-(4-hydroxyphenyl)-2-(4-methoxyphenyl)ethane increases chemical synthesis ISO RGD:1346751 6480464 CYP2B6 protein results in increased chemical synthesis of 1 more ... CTD PMID:9733665 1,1,1-Trichloro-2-(4-hydroxyphenyl)-2-(4-methoxyphenyl)ethane increases hydroxylation ISO RGD:1346751 6480464 CYP2B6 protein results in increased hydroxylation of 1 more ... CTD PMID:12167570 , PMID:9047321 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression ISO RGD:1346751 6480464 o more ... CTD PMID:15548381 , PMID:21924250 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane multiple interactions ISO RGD:1346751 6480464 o, p'-DDT inhibits the reaction [Androstenols inhibits the reaction [NR1I3 protein results in increased expression of CYP2B6 mRNA]] CTD PMID:10037683 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane affects expression ISO RGD:1624098 6480464 o, p'-DDT affects the expression of CYP2B9 mRNA CTD PMID:18925944 1,4-naphthoquinone increases abundance ISO RGD:1346751 6480464 CYP2B6 protein results in increased abundance of 1, 4-naphthoquinone CTD PMID:16243959 1,8-cineole multiple interactions ISO RGD:1346751 6480464 Eucalyptol inhibits the reaction [CYP2B6 protein results in increased hydrolysis of Bupropion] CTD PMID:18611395 1-\{2-[(4-chlorobenzyl)sulfanyl]-2-(2,4-dichlorophenyl)ethyl\}-1H-imidazole multiple interactions ISO RGD:1346751 6480464 [sulconazole co-treated with NR1I3 protein alternative form] results in increased expression of CYP2B6 mRNA, [sulconazole co-treated with NR1I3 protein mutant form] results in increased expression of CYP2B6 mRNA CTD PMID:31312845 1-\{2-[(4-chlorobenzyl)sulfanyl]-2-(2,4-dichlorophenyl)ethyl\}-1H-imidazole increases expression ISO RGD:1346751 6480464 sulconazole results in increased expression of CYP2B6 mRNA CTD PMID:31312845 1-naphthol increases abundance ISO RGD:1346751 6480464 CYP2B6 protein results in increased abundance of 1-naphthol CTD PMID:16243959 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of CYP2B6 mRNA CTD PMID:20551477 17alpha-ethynylestradiol multiple interactions ISO RGD:1346751 6480464 [Ethinyl Estradiol co-treated with NADP] results in decreased activity of CYP2B6 protein CTD PMID:11805216 , PMID:16485904 17alpha-ethynylestradiol affects metabolic processing ISO RGD:1346751 6480464 CYP2B6 protein affects the metabolism of Ethinyl Estradiol CTD PMID:16485904 17beta-estradiol multiple interactions ISO RGD:1346751 6480464 [Progesterone co-treated with Estradiol] inhibits the reaction [6-(4-chlorophenyl)imidazo(2 more ... CTD PMID:20079471 , PMID:21768169 17beta-estradiol multiple interactions EXP 6480464 [Estradiol co-treated with Plant Preparations] results in decreased expression of CYP2B3 mRNA CTD PMID:26945725 17beta-estradiol increases expression ISO RGD:1346751 6480464 Estradiol results in increased expression of CYP2B6 mRNA CTD PMID:20079471 , PMID:22837389 2,2',3,3',6,6'-hexachlorobiphenyl increases expression ISO RGD:1624098 6480464 2 more ... CTD PMID:28431184 2,2',4,4',5,5'-hexachlorobiphenyl increases expression ISO RGD:1624098 6480464 2 more ... CTD PMID:20005886 , PMID:21851831 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1624098 6480464 [2 more ... CTD PMID:25510870 2,2',4,4'-Tetrabromodiphenyl ether multiple interactions ISO RGD:1346751 6480464 [2 more ... CTD PMID:24218150 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:1346751 6480464 2 more ... CTD PMID:31173147 2,2',4,4'-Tetrabromodiphenyl ether increases metabolic processing ISO RGD:1346751 6480464 CYP2B6 protein results in increased metabolism of 2 more ... CTD PMID:23249762 , PMID:23537005 2,2',4,4'-Tetrabromodiphenyl ether increases chemical synthesis ISO RGD:1346751 6480464 CYP2B6 protein results in increased chemical synthesis of 2 more ... CTD PMID:23249762 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:1346751 6480464 2 more ... CTD PMID:24218150 2,2',4,5'-Tetrabromodiphenyl ether increases chemical synthesis ISO RGD:1346751 6480464 CYP2B6 protein results in increased chemical synthesis of 2 more ... CTD PMID:23249762 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:1624098 6480464 [2 more ... CTD PMID:25510870 2,3',4,4',5-Pentachlorobiphenyl increases metabolic processing ISO RGD:1346751 6480464 CYP2B6 protein results in increased metabolism of 2 more ... CTD PMID:27208082 2,3',4,4',5-Pentachlorobiphenyl affects response to substance ISO RGD:1346751 6480464 CYP2B6 gene SNP affects the susceptibility to 2 more ... CTD PMID:25839716 2,3,4,3',4'-Pentachlorobiphenyl affects response to substance ISO RGD:1346751 6480464 CYP2B6 gene SNP affects the susceptibility to 2 more ... CTD PMID:25839716 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP2B3 mRNA CTD PMID:19692669 , PMID:32387183 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1624098 6480464 Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CYP2B9 gene] CTD PMID:28213091 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1624098 6480464 Tetrachlorodibenzodioxin results in increased expression of CYP2B9 mRNA CTD PMID:28213091 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1346751 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP2B6 mRNA CTD PMID:23669205 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1346751 6480464 Tetrachlorodibenzodioxin results in increased expression of CYP2B6 mRNA CTD PMID:20106945 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1624098 6480464 Tetrachlorodibenzodioxin affects the expression of CYP2B9 mRNA CTD PMID:21570461 , PMID:28922406 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases metabolic processing ISO RGD:1346751 6480464 CYP2B6 protein results in increased metabolism of 2 more ... CTD PMID:22738989 2,6-di-tert-butyl-4-methylphenol increases expression ISO RGD:1346751 6480464 Butylated Hydroxytoluene results in increased expression of CYP2B6 mRNA CTD PMID:18570159 2,8-bis-Trifluoromethyl-4-quinoline carboxylic acid increases expression ISO RGD:1346751 6480464 Ro 21-5104 results in increased expression of CYP2B6 mRNA, Ro 21-5104 results in increased expression of CYP2B6 protein CTD PMID:25313206 2,8-bis-Trifluoromethyl-4-quinoline carboxylic acid multiple interactions ISO RGD:1346751 6480464 NR1I2 mRNA promotes the reaction [Ro 21-5104 results in increased expression of CYP2B6 mRNA] CTD PMID:25313206 2-Dechloroethylifosfamide affects chemical synthesis ISO RGD:1346751 6480464 CYP2B6 protein affects the chemical synthesis of dechloroethylifosfamide CTD PMID:15875221 2-n-Propyl-4-pentenoic acid increases chemical synthesis ISO RGD:1346751 6480464 CYP2B6 protein results in increased chemical synthesis of 2-propyl-4-pentenoic acid CTD PMID:16945988 2-Naphthalenethiol increases expression ISO RGD:1346751 6480464 2-naphthalenethiol results in increased expression of CYP2B6 mRNA CTD PMID:36356836 2-naphthol increases abundance ISO RGD:1346751 6480464 CYP2B6 protein results in increased abundance of 2-naphthol CTD PMID:16243959 2-nitroanisole increases oxidation ISO RGD:1346751 6480464 CYP2B6 protein results in increased oxidation of 2-nitroanisole CTD PMID:17159769 , PMID:21218109 2-nitroanisole increases metabolic processing ISO RGD:1346751 6480464 CYP2B6 protein results in increased metabolism of 2-nitroanisole CTD PMID:15144223 2-nitrophenol affects chemical synthesis ISO RGD:1346751 6480464 CYP2B6 protein affects the chemical synthesis of 2-nitrophenol CTD PMID:11409192 2-nitrophenol affects chemical synthesis EXP 6480464 CYP2B6 protein affects the chemical synthesis of 2-nitrophenol CTD PMID:11409192 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:19692669 3,3',4,4',5-pentachlorobiphenyl multiple interactions EXP 6480464 AHR gene mutant form inhibits the reaction [3 more ... CTD PMID:34256052 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:34256052 3,3',4,4',5-pentachlorobiphenyl increases expression ISO RGD:1346751 6480464 3 more ... CTD PMID:19692669 3,3',5,5'-tetrabromobisphenol A increases expression EXP 6480464 tetrabromobisphenol A results in increased expression of CYP2B6 mRNA CTD PMID:27914987 3,5-xylenol multiple interactions ISO RGD:1346751 6480464 [CYP2B6 protein results in increased oxidation of 3, 5-xylenol analog] which results in increased abundance of 4-(methylsulfinyl)phenol analog CTD PMID:27665777 3,5-xylenol increases oxidation ISO RGD:1346751 6480464 CYP2B6 protein results in increased oxidation of 3, 5-xylenol analog CTD PMID:27665777 3-chloropropane-1,2-diol decreases expression EXP 6480464 alpha-Chlorohydrin results in decreased expression of CYP2B6 mRNA CTD PMID:28522335 3-methylcholanthrene decreases expression EXP 6480464 Methylcholanthrene results in decreased expression of CYP2B3 mRNA CTD PMID:11328961 3-methylcholanthrene increases expression ISO RGD:1624098 6480464 Methylcholanthrene results in increased expression of CYP2B9 mRNA CTD PMID:30503582 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1, 2-dithiol-3-thione results in decreased expression of CYP2B3 mRNA CTD PMID:19162173 4,4'-diaminodiphenylmethane increases expression ISO RGD:1624098 6480464 4, 4'-diaminodiphenylmethane results in increased expression of CYP2B9 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol affects expression ISO RGD:1624098 6480464 bis(4-hydroxyphenyl)sulfone affects the expression of CYP2B9 mRNA CTD PMID:31683443 4-(methylsulfinyl)phenol multiple interactions ISO RGD:1346751 6480464 [CYP2B6 protein results in increased oxidation of 3, 5-xylenol analog] which results in increased abundance of 4-(methylsulfinyl)phenol analog CTD PMID:27665777 4-(methylsulfinyl)phenol increases abundance ISO RGD:1346751 6480464 CYP2B6 protein results in increased abundance of 4-(methylsulfinyl)phenol analog CTD PMID:27665777 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases activity ISO RGD:1346751 6480464 CYP2B6 protein results in increased activity of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone CTD PMID:10799646 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one multiple interactions ISO RGD:1346751 6480464 [CYP2B6 protein co-treated with cupric chloride co-treated with NADP] results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone CTD PMID:32672941 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one affects metabolic processing ISO RGD:1346751 6480464 CYP2B6 protein affects the metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone CTD PMID:12920169 4-[(1E)-1,2-diphenylbut-1-en-1-yl]phenol increases abundance ISO RGD:1346751 6480464 CYP2B6 protein results in increased abundance of 1-(4-hydroxyphenyl)-1, 2-diphenyl-1-butene CTD PMID:29285606 4-[(1E)-1,2-diphenylbut-1-en-1-yl]phenol multiple interactions ISO RGD:1346751 6480464 [CYP2B6 protein results in increased metabolism of 1-(4-hydroxyphenyl)-1 more ... CTD PMID:29285606 4-[(1E)-1,2-diphenylbut-1-en-1-yl]phenol increases metabolic processing ISO RGD:1346751 6480464 CYP2B6 protein results in increased metabolism of 1-(4-hydroxyphenyl)-1, 2-diphenyl-1-butene CTD PMID:29285606 4-Aminophenyl ether increases expression ISO RGD:1346751 6480464 di-(4-aminophenyl)ether results in increased expression of CYP2B6 mRNA CTD PMID:36356836 4-bromo-2-chlorophenol multiple interactions ISO RGD:1346751 6480464 [CYP2B6 protein results in increased metabolism of profenofos] which results in increased abundance of 4-bromo-2-chlorophenol CTD PMID:23415833 4-Hydroxy-N-desmethyltamoxifen increases metabolic processing ISO RGD:1346751 6480464 CYP2B6 protein results in increased metabolism of 4-hydroxy-N-desmethyltamoxifen CTD PMID:29285606 4-Hydroxy-N-desmethyltamoxifen multiple interactions ISO RGD:1346751 6480464 [CYP2B6 protein results in increased metabolism of 4-hydroxy-N-desmethyltamoxifen] which results in increased abundance of 4-hydroxy-N-desmethyltamoxifen metabolite CTD PMID:29285606 4-hydroxycyclophosphamide increases chemical synthesis ISO RGD:1346751 6480464 CYP2B6 protein results in increased chemical synthesis of 4-hydroxycyclophosphamide CTD PMID:24819615 4-hydroxynon-2-enal multiple interactions ISO RGD:1346751 6480464 [CYP2B6 protein results in increased oxidation of 4-hydroxy-2-nonenal] which results in increased chemical synthesis of 4-hydroxy-2-nonenoic acid more ... CTD PMID:21766881 4-Hydroxyvalproic acid increases chemical synthesis ISO RGD:1346751 6480464 CYP2B6 protein results in increased chemical synthesis of 4-hydroxyvalproate CTD PMID:16945988 4-nonylphenol increases expression ISO RGD:1346751 6480464 4-nonylphenol results in increased expression of CYP2B6 mRNA CTD PMID:17483497 4-nonylphenol multiple interactions ISO RGD:1346751 6480464 4-nonylphenol promotes the reaction [NR1I3 protein results in increased expression of CYP2B10 mRNA] CTD PMID:17483497 5-hydroxydiclofenac multiple interactions ISO RGD:1346751 6480464 [CYP2B6 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 5-hydroxydiclofenac CTD PMID:24246759 5-Hydroxyflavone increases oxidation ISO RGD:1346751 6480464 CYP2B6 protein results in increased oxidation of 5-hydroxyflavone CTD PMID:30964977 5-Hydroxyvalproic acid increases chemical synthesis ISO RGD:1346751 6480464 CYP2B6 protein results in increased chemical synthesis of 5-hydroxyvalproate CTD PMID:16945988 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole increases expression ISO RGD:1346751 6480464 Omeprazole results in increased expression of CYP2B6 mRNA CTD PMID:17954527 more ... 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole increases activity ISO RGD:1346751 6480464 Omeprazole results in increased activity of CYP2B6 protein CTD PMID:19118567 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole affects expression EXP 6480464 Omeprazole affects the expression of CYP2B3 mRNA CTD PMID:19483382 5-methoxy-N,N-diisopropyltryptamine decreases activity ISO RGD:1346751 6480464 5-methoxy-N, N-diisopropyltryptamine analog results in decreased activity of CYP2B6 protein CTD PMID:26599973 5-methoxy-N,N-diisopropyltryptamine multiple interactions ISO RGD:1346751 6480464 [5-methoxy-N, N-diisopropyltryptamine analog results in decreased activity of CYP2B6 protein] which results in decreased metabolism of Bupropion CTD PMID:26599973 6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime multiple interactions ISO RGD:1346751 6480464 6-(4-chlorophenyl)imidazo(2 more ... CTD PMID:16608920 more ... 6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime increases expression ISO RGD:1346751 6480464 6-(4-chlorophenyl)imidazo(2 more ... CTD PMID:16608920 more ... 6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime increases activity ISO RGD:1346751 6480464 6-(4-chlorophenyl)imidazo(2 more ... CTD PMID:19202563 more ... 6-propyl-2-thiouracil affects expression EXP 6480464 Propylthiouracil affects the expression of CYP2B3 mRNA CTD PMID:19483382 7,12-dimethyltetraphene multiple interactions ISO RGD:1346751 6480464 CYP2B6 protein results in increased metabolism of and results in increased activity of 9 more ... CTD PMID:32159784 9-cis-retinoic acid multiple interactions ISO RGD:1346751 6480464 RXRA protein affects the reaction [Alitretinoin results in increased expression of CYP2B6 mRNA] CTD PMID:31312845 9-cis-retinoic acid increases expression ISO RGD:1346751 6480464 Alitretinoin results in increased expression of CYP2B6 mRNA CTD PMID:31312845 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of CYP2B3 mRNA CTD PMID:31881176 acetochlor increases metabolic processing ISO RGD:1346751 6480464 CYP2B6 protein results in increased metabolism of acetochlor CTD PMID:11133395 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of CYP2B3 mRNA CTD PMID:28959563 afimoxifene multiple interactions ISO RGD:1346751 6480464 [CYP2B6 protein results in increased metabolism of afimoxifene] which results in increased abundance of afimoxifene metabolite CTD PMID:29285606 afimoxifene increases metabolic processing ISO RGD:1346751 6480464 CYP2B6 protein results in increased metabolism of afimoxifene CTD PMID:29285606 aflatoxin B1 affects expression ISO RGD:1346751 6480464 Aflatoxin B1 affects the expression of CYP2B6 protein CTD PMID:20106945 aflatoxin B1 decreases expression ISO RGD:1346751 6480464 Aflatoxin B1 results in decreased expression of CYP2B6 mRNA CTD PMID:27153756 aflatoxin B1 increases expression ISO RGD:1346751 6480464 Aflatoxin B1 results in increased expression of CYP2B6 mRNA CTD PMID:21994236 alachlor decreases response to substance ISO RGD:1346751 6480464 CYP2B6 protein results in decreased susceptibility to alachlor CTD PMID:16277416 aldrin increases expression ISO RGD:1346751 6480464 Aldrin results in increased expression of CYP2B6 protein CTD PMID:15548381 allyl isothiocyanate multiple interactions ISO RGD:1346751 6480464 allyl isothiocyanate inhibits the reaction [6-(4-chlorophenyl)imidazo(2 more ... CTD PMID:25069801 Aloe emodin multiple interactions ISO RGD:1346751 6480464 [CYP2B6 protein results in increased metabolism of chrysophanic acid] which results in increased chemical synthesis of aloe emodin CTD PMID:29698620 Aloe emodin increases chemical synthesis ISO RGD:1346751 6480464 CYP2B6 protein results in increased chemical synthesis of aloe emodin CTD PMID:29698620 alpha-methyltryptamine multiple interactions ISO RGD:1346751 6480464 [indopan analog results in decreased activity of CYP2B6 protein] which results in decreased metabolism of Bupropion, [indopan results in decreased activity of CYP2B6 protein] which results in decreased metabolism of Bupropion CTD PMID:26599973 alpha-methyltryptamine decreases activity ISO RGD:1346751 6480464 indopan analog results in decreased activity of CYP2B6 protein, indopan results in decreased activity of CYP2B6 protein CTD PMID:26599973 aminoguanidine multiple interactions ISO RGD:1346751 6480464 pimagedine inhibits the reaction [Phenytoin results in increased expression of CYP2B6 mRNA] CTD PMID:18206661 amiodarone affects expression EXP 6480464 Amiodarone affects the expression of CYP2B3 mRNA CTD PMID:19483382 amiodarone decreases response to substance ISO RGD:1346751 6480464 CYP2B6 protein results in decreased susceptibility to Amiodarone CTD PMID:26477383 amitriptyline increases metabolic processing ISO RGD:1346751 6480464 CYP2B6 protein results in increased metabolism of Amitriptyline CTD PMID:27320963 amitriptylinoxide increases abundance ISO RGD:1346751 6480464 CYP2B6 protein results in increased abundance of amitriptyline N-oxide CTD PMID:27320963 amlodipine decreases activity ISO RGD:1346751 6480464 Amlodipine results in decreased activity of CYP2B6 protein CTD PMID:10805063 amodiaquine increases metabolic processing ISO RGD:1346751 6480464 CYP2B6 protein results in increased metabolism of Amodiaquine CTD PMID:31629065 amodiaquine multiple interactions ISO RGD:1346751 6480464 [CYP2B6 protein results in increased metabolism of Amodiaquine] which results in increased abundance of desethylamodiaquine CTD PMID:31629065 amphetamine increases hydroxylation ISO RGD:1346751 6480464 CYP2B6 protein results in increased hydroxylation of Amphetamine analog CTD PMID:29277574 amphetamine decreases methylation ISO RGD:1346751 6480464 CYP2B6 protein results in decreased methylation of Amphetamine analog CTD PMID:29277574 amphetamine affects chemical synthesis ISO RGD:1346751 6480464 CYP2B6 protein affects the chemical synthesis of Amphetamine CTD PMID:15294457 andrographolide multiple interactions ISO RGD:1624098 6480464 [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of CYP2B9 mRNA CTD PMID:19737545 andrographolide increases expression ISO RGD:1624098 6480464 andrographolide results in increased expression of CYP2B9 mRNA CTD PMID:19737545 androst-4-ene-3,17-dione increases expression ISO RGD:1624098 6480464 Androstenedione results in increased expression of CYP2B9 mRNA CTD PMID:7771797 aniline multiple interactions ISO RGD:1346751 6480464 CYP2B6 protein affects the metabolism of [norharman co-treated with aniline] CTD PMID:15279827 arachidonic acid increases metabolic processing ISO RGD:1346751 6480464 CYP2B6 protein results in increased metabolism of Arachidonic Acid CTD PMID:12675279 Aroclor 1254 decreases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of CYP2B3 mRNA CTD PMID:18178546 Aroclor 1254 increases expression ISO RGD:1346751 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of CYP2B6 mRNA, Chlorodiphenyl (54% Chlorine) results in increased expression of CYP2B6 protein CTD PMID:17851650 arsane increases expression ISO RGD:1624098 6480464 Arsenic results in increased expression of CYP2B9 mRNA CTD PMID:15026472 arsenic atom increases expression ISO RGD:1624098 6480464 Arsenic results in increased expression of CYP2B9 mRNA CTD PMID:15026472 artemether multiple interactions ISO RGD:1346751 6480464 [Artemether co-treated with NR1I3 protein alternative form] results in increased expression of CYP2B6 mRNA CTD PMID:31312845 atazanavir sulfate multiple interactions ISO RGD:1346751 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CYP2B6 mRNA CTD PMID:32152650 atazanavir sulfate decreases expression ISO RGD:1346751 6480464 Atazanavir Sulfate results in decreased expression of CYP2B6 mRNA CTD PMID:32152650 atorvastatin calcium increases expression ISO RGD:1346751 6480464 Atorvastatin results in increased expression of CYP2B6 mRNA CTD PMID:15802384 atrazine increases activity ISO RGD:1346751 6480464 Atrazine results in increased activity of CYP2B6 protein CTD PMID:22310298 atrazine affects methylation EXP 6480464 Atrazine affects the methylation of CYP2B3 gene CTD PMID:35440735 atrazine increases expression ISO RGD:1624098 6480464 Atrazine results in increased expression of CYP2B9 mRNA CTD PMID:26775023 atrazine multiple interactions ISO RGD:1624098 6480464 [Atrazine co-treated with Chlorpyrifos co-treated with Endosulfan] results in decreased expression of CYP2B9 mRNA, lycopene affects the reaction [Atrazine results in increased expression of CYP2B9 mRNA] CTD PMID:22515965 , PMID:26775023 atrazine increases expression ISO RGD:1346751 6480464 Atrazine results in increased expression of CYP2B6 mRNA CTD PMID:22310298 , PMID:22515965 atrazine multiple interactions ISO RGD:1346751 6480464 [Atrazine co-treated with Chlorpyrifos co-treated with Endosulfan] results in increased expression of CYP2B6 mRNA more ... CTD PMID:16608219 , PMID:22515965 Avasimibe multiple interactions ISO RGD:1346751 6480464 avasimibe results in increased expression of and results in increased activity of CYP2B6 protein CTD PMID:15333513 Avasimibe increases expression ISO RGD:1346751 6480464 avasimibe results in increased expression of CYP2B6 mRNA CTD PMID:15333513 azoxystrobin multiple interactions ISO RGD:1346751 6480464 [cyproconazole co-treated with azoxystrobin] results in increased expression of CYP2B6 protein CTD PMID:29294346 azoxystrobin increases expression ISO RGD:1346751 6480464 azoxystrobin results in increased expression of CYP2B6 protein CTD PMID:29294346 baicalein increases expression ISO RGD:1346751 6480464 baicalein results in increased expression of CYP2B6 mRNA CTD PMID:25625231 barnidipine decreases activity ISO RGD:1346751 6480464 mepirodipine results in decreased activity of CYP2B6 protein CTD PMID:10805063 benfuracarb increases activity ISO RGD:1346751 6480464 benfuracarb results in increased activity of CYP2B6 protein CTD PMID:22310298 benfuracarb increases expression ISO RGD:1346751 6480464 benfuracarb results in increased expression of CYP2B6 mRNA CTD PMID:22310298 benidipine increases expression ISO RGD:1346751 6480464 benidipine results in increased expression of CYP2B6 mRNA, benidipine results in increased expression of CYP2B6 protein CTD PMID:27732883 benzbromarone affects expression EXP 6480464 Benzbromarone affects the expression of CYP2B3 mRNA CTD PMID:19483382 benzene decreases expression ISO RGD:1624098 6480464 Benzene results in decreased expression of CYP2B9 mRNA CTD PMID:34624356 benzo[a]pyrene increases mutagenesis ISO RGD:1346751 6480464 Benzo(a)pyrene results in increased mutagenesis of CYP2B6 gene CTD PMID:25435355 benzo[a]pyrene decreases expression ISO RGD:1346751 6480464 Benzo(a)pyrene results in decreased expression of CYP2B6 mRNA CTD PMID:32234424 benzo[a]pyrene increases methylation ISO RGD:1346751 6480464 Benzo(a)pyrene results in increased methylation of CYP2B6 3' UTR, Benzo(a)pyrene results in increased methylation of CYP2B6 promoter CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:1346751 6480464 Benzo(a)pyrene affects the methylation of CYP2B6 exon CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1624098 6480464 Benzo(a)pyrene results in increased expression of CYP2B9 mRNA, Benzo(a)pyrene results in increased expression of CYP2B9 protein CTD PMID:21964900 , PMID:34472326 benzo[a]pyrene multiple interactions ISO RGD:1346751 6480464 [Benzo(a)pyrene co-treated with 1 more ... CTD PMID:17690111 , PMID:33249052 benzo[a]pyrene increases expression ISO RGD:1346751 6480464 Benzo(a)pyrene results in increased expression of CYP2B6 mRNA CTD PMID:15735009 benzo[a]pyrene affects expression ISO RGD:1346751 6480464 Benzo(a)pyrene affects the expression of CYP2B6 mRNA CTD PMID:20106945 benzo[a]pyrene diol epoxide I affects response to substance ISO RGD:1346751 6480464 CYP2B6 gene SNP affects the susceptibility to 7 more ... CTD PMID:22521834 benzo[a]pyrene diol epoxide I increases expression ISO RGD:1346751 6480464 7 more ... CTD PMID:19150397 benzo[a]pyrene diol epoxide I multiple interactions ISO RGD:1346751 6480464 CYP2B6 gene SNP affects the reaction [7 more ... CTD PMID:22521834 benzphetamine increases metabolic processing ISO RGD:1346751 6480464 CYP2B6 protein results in increased metabolism of Benzphetamine CTD PMID:12464242 , PMID:15769884 berberine multiple interactions ISO RGD:1624098 6480464 Berberine promotes the reaction [Phenobarbital results in increased expression of CYP2B9 mRNA], Berberine promotes the reaction [Streptozocin results in increased expression of CYP2B9 mRNA] CTD PMID:22342832 berberine increases expression ISO RGD:1624098 6480464 Berberine results in increased expression of CYP2B9 mRNA CTD PMID:22342832 bergomottin decreases activity ISO RGD:1346751 6480464 bergamottin results in decreased activity of CYP2B6 protein CTD PMID:15769884 beta-carboline multiple interactions ISO RGD:1346751 6480464 CYP2B6 protein affects the metabolism of [norharman co-treated with aniline] CTD PMID:15279827 beta-naphthoflavone increases activity ISO RGD:1346751 6480464 beta-Naphthoflavone results in increased activity of CYP2B6 protein CTD PMID:19497361 , PMID:22258563 beta-naphthoflavone increases expression ISO RGD:1346751 6480464 beta-Naphthoflavone results in increased expression of CYP2B6 mRNA CTD PMID:19118567 beta-naphthoflavone multiple interactions ISO RGD:1624098 6480464 [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of CYP2B9 mRNA CTD PMID:19737545 beta-naphthoflavone increases expression ISO RGD:1624098 6480464 beta-Naphthoflavone results in increased expression of CYP2B9 mRNA CTD PMID:19737545 bexarotene increases expression ISO RGD:1346751 6480464 Bexarotene results in increased expression of CYP2B6 mRNA CTD PMID:31312845 bexarotene multiple interactions ISO RGD:1346751 6480464 RXRA protein affects the reaction [Bexarotene results in increased expression of CYP2B6 mRNA] CTD PMID:31312845 bilirubin IXalpha increases expression ISO RGD:1346751 6480464 Bilirubin results in increased expression of CYP2B6 mRNA CTD PMID:15382119 bilirubin IXalpha multiple interactions ISO RGD:1346751 6480464 IL1B protein inhibits the reaction [Bilirubin results in increased expression of CYP2B6 mRNA] CTD PMID:15382119 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1624098 6480464 Diethylhexyl Phthalate results in increased expression of CYP2B9 mRNA CTD PMID:19850644 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1346751 6480464 Diethylhexyl Phthalate results in decreased expression of CYP2B6 mRNA CTD PMID:31163220 bisphenol A affects expression ISO RGD:1346751 6480464 bisphenol A affects the expression of CYP2B6 mRNA CTD PMID:24793377 bisphenol A increases expression ISO RGD:1346751 6480464 bisphenol A results in increased expression of CYP2B6 mRNA CTD PMID:26196221 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CYP2B6 mRNA CTD PMID:25181051 bosentan increases expression ISO RGD:1346751 6480464 Bosentan results in increased expression of CYP2B6 mRNA CTD PMID:18332078 , PMID:29761207 brucine increases expression EXP 6480464 brucine results in increased expression of CYP2B3 protein CTD PMID:8850324 bupropion multiple interactions ISO RGD:1346751 6480464 2-(4'-methoxybenzenesulfonyl)-2 more ... CTD PMID:18611395 more ... bupropion increases hydroxylation ISO RGD:1346751 6480464 CYP2B6 protein results in increased hydroxylation of Bupropion CTD PMID:22634058 more ... bupropion increases metabolic processing ISO RGD:1346751 6480464 CYP2B6 protein results in increased metabolism of Bupropion CTD PMID:15155557 more ... bupropion increases hydrolysis ISO RGD:1346751 6480464 CYP2B6 protein results in increased hydrolysis of Bupropion CTD PMID:18611395 bupropion affects metabolic processing ISO RGD:1346751 6480464 CYP2B6 protein affects the metabolism of Bupropion CTD PMID:15626586 butachlor increases metabolic processing ISO RGD:1346751 6480464 CYP2B6 protein results in increased metabolism of butachlor CTD PMID:11133395 butyric acid increases expression ISO RGD:1346751 6480464 Butyric Acid results in increased expression of CYP2B6 mRNA CTD PMID:30439556 C.I. Natural Red 20 decreases activity ISO RGD:1346751 6480464 shikonin results in decreased activity of CYP2B6 protein CTD PMID:28941798 C60 fullerene increases expression EXP 6480464 fullerene C60 results in increased expression of CYP2B3 mRNA CTD PMID:19167457 cadmium sulfate multiple interactions ISO RGD:1624098 6480464 cadmium sulfate affects the reaction [MTF1 affects the expression of CYP2B9 mRNA] CTD PMID:16221973 calciol increases expression ISO RGD:1346751 6480464 Cholecalciferol metabolite results in increased expression of CYP2B6 CTD PMID:11991950 camphor multiple interactions ISO RGD:1346751 6480464 Camphor inhibits the reaction [CYP2B6 protein results in increased hydrolysis of Bupropion] CTD PMID:18611395 camptothecin decreases expression ISO RGD:1346751 6480464 Camptothecin results in decreased expression of CYP2B6 mRNA CTD PMID:29356861 camptothecin multiple interactions ISO RGD:1346751 6480464 Camptothecin inhibits the reaction [Rifampin results in increased expression of CYP2B6 mRNA] CTD PMID:29356861 cannabidiol decreases activity ISO RGD:1346751 6480464 Cannabidiol results in decreased activity of CYP2B6 protein CTD PMID:24667653 captan multiple interactions ISO RGD:1624098 6480464 [Dietary Fats co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Captan co-treated with Chlorpyrifos co-treated with thiacloprid co-treated with Thiophanate co-treated with Ziram] results in increased expression of CYP2B9 mRNA CTD PMID:32745781 carbamazepine increases expression ISO RGD:1346751 6480464 Carbamazepine results in increased expression of CYP2B6 mRNA, Carbamazepine results in increased expression of CYP2B6 protein CTD PMID:14977870 , PMID:17112801 carbamazepine multiple interactions ISO RGD:1346751 6480464 [Carbamazepine results in increased activity of NR1I3 protein alternative form] which results in increased expression of CYP2B6 mRNA, [Carbamazepine results in increased activity of NR1I3 protein] which results in increased expression of CYP2B6 mRNA CTD PMID:17041008 carbaryl increases activity ISO RGD:1346751 6480464 Carbaryl results in increased activity of CYP2B6 protein CTD PMID:22310298 carbaryl increases expression ISO RGD:1346751 6480464 Carbaryl results in increased expression of CYP2B6 mRNA CTD PMID:22310298 carbendazim increases expression ISO RGD:1346751 6480464 carbendazim results in increased expression of CYP2B6 mRNA CTD PMID:22310298 carbofuran increases activity ISO RGD:1346751 6480464 Carbofuran results in increased activity of CYP2B6 protein CTD PMID:22310298 carbofuran increases expression ISO RGD:1346751 6480464 Carbofuran results in increased expression of CYP2B6 mRNA CTD PMID:22310298 carbon nanotube affects expression ISO RGD:1624098 6480464 Nanotubes, Carbon affects the expression of CYP2B9 mRNA CTD PMID:25554681 carbon nanotube decreases expression ISO RGD:1624098 6480464 Nanotubes, Carbon results in decreased expression of CYP2B9 mRNA CTD PMID:25620056 carbosulfan increases metabolic processing ISO RGD:1346751 6480464 CYP2B6 protein results in increased metabolism of carbosulfan CTD PMID:20307514 carbosulfan increases expression ISO RGD:1346751 6480464 carbosulfan results in increased expression of CYP2B6 mRNA CTD PMID:22310298 carbosulfan increases activity ISO RGD:1346751 6480464 carbosulfan results in increased activity of CYP2B6 protein CTD PMID:22310298 cerivastatin increases expression ISO RGD:1346751 6480464 cerivastatin results in increased expression of CYP2B6 mRNA CTD PMID:15802384 CGP 52608 multiple interactions ISO RGD:1346751 6480464 CGP 52608 promotes the reaction [RORA protein binds to CYP2B6 gene] CTD PMID:28238834 Chalepensin increases expression ISO RGD:1624098 6480464 3-(alpha, alpha-dimethylallyl)psoralen results in increased expression of CYP2B9 mRNA CTD PMID:22790670 chenodeoxycholic acid multiple interactions ISO RGD:1346751 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CYP2B6 mRNA more ... CTD PMID:32152650 , PMID:33819548 chlordecone increases expression ISO RGD:1346751 6480464 Chlordecone results in increased expression of CYP2B6 protein CTD PMID:15548381 chlorfluazuron increases activity ISO RGD:1346751 6480464 chlorfluazuron results in increased activity of CYP2B6 protein CTD PMID:22310298 chlorfluazuron increases expression ISO RGD:1346751 6480464 chlorfluazuron results in increased expression of CYP2B6 mRNA CTD PMID:22310298 chlorotoluron multiple interactions ISO RGD:1346751 6480464 CYP2B6 protein results in increased metabolism of and results in decreased susceptibility to chlortoluron CTD PMID:15853388 chlorpromazine multiple interactions ISO RGD:1346751 6480464 [Chlorpromazine results in increased activity of NR1I3 protein alternative form] which results in increased expression of CYP2B6 mRNA, Chlorpromazine inhibits the reaction [Androstenols inhibits the reaction [NR1I3 protein results in increased expression of CYP2B6 mRNA]] CTD PMID:10037683 , PMID:17041008 chlorpromazine decreases response to substance ISO RGD:1346751 6480464 CYP2B6 protein results in decreased susceptibility to Chlorpromazine CTD PMID:26477383 chlorpyrifos multiple interactions ISO RGD:1346751 6480464 [Atrazine co-treated with Chlorpyrifos co-treated with Endosulfan] results in increased expression of CYP2B6 mRNA more ... CTD PMID:11854147 more ... chlorpyrifos decreases activity ISO RGD:1346751 6480464 Chlorpyrifos results in decreased activity of CYP2B6 protein CTD PMID:20183062 more ... chlorpyrifos multiple interactions ISO RGD:1624098 6480464 [Atrazine co-treated with Chlorpyrifos co-treated with Endosulfan] results in decreased expression of CYP2B9 mRNA, [Dietary Fats co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Captan co-treated with Chlorpyrifos co-treated with thiacloprid co-treated with Thiophanate co-treated with Ziram] results in increased expression of CYP2B9 mRNA CTD PMID:22515965 , PMID:32745781 chlorpyrifos increases activity ISO RGD:1346751 6480464 CYP2B6 protein results in increased activity of Chlorpyrifos CTD PMID:22281205 chlorpyrifos decreases sulfation ISO RGD:1346751 6480464 CYP2B6 protein results in decreased sulfation of Chlorpyrifos CTD PMID:17079358 chlorpyrifos affects metabolic processing ISO RGD:1346751 6480464 CYP2B6 protein affects the metabolism of Chlorpyrifos CTD PMID:15557345 , PMID:17079358 chlorpyrifos increases metabolic processing ISO RGD:1346751 6480464 CYP2B6 results in increased metabolism of Chlorpyrifos CTD PMID:20709133 chlorpyrifos increases expression ISO RGD:1346751 6480464 Chlorpyrifos results in increased expression of CYP2B6 mRNA, Chlorpyrifos results in increased expression of CYP2B6 protein CTD PMID:15548381 more ... cholic acid increases expression ISO RGD:1624098 6480464 Cholic Acid results in increased expression of CYP2B9 mRNA CTD PMID:17521389 choline multiple interactions ISO RGD:1624098 6480464 [Choline deficiency co-treated with Folic Acid deficiency co-treated with Methionine deficiency] results in increased expression of CYP2B9 mRNA, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CYP2B9 mRNA CTD PMID:20938992 , PMID:29127188 chromium(6+) affects expression ISO RGD:1624098 6480464 chromium hexavalent ion affects the expression of CYP2B9 mRNA CTD PMID:28472532 chrysin increases expression ISO RGD:1346751 6480464 chrysin results in increased expression of CYP2B6 mRNA CTD PMID:25625231 chrysophanol multiple interactions ISO RGD:1346751 6480464 [CYP2B6 protein results in increased metabolism of chrysophanic acid] which results in increased chemical synthesis of aloe emodin CTD PMID:29698620 chrysophanol increases metabolic processing ISO RGD:1346751 6480464 CYP2B6 protein results in increased metabolism of chrysophanic acid CTD PMID:29698620 ciguatoxin CTX1B affects expression ISO RGD:1624098 6480464 Ciguatoxins affects the expression of CYP2B9 mRNA CTD PMID:18353800 cimetidine decreases expression ISO RGD:1346751 6480464 Cimetidine results in decreased expression of CYP2B6 protein CTD PMID:22733800 cimetidine decreases activity ISO RGD:1346751 6480464 Cimetidine results in decreased activity of CYP2B6 protein CTD PMID:22733800 cimetidine multiple interactions ISO RGD:1346751 6480464 [Monocrotophos co-treated with Cimetidine] results in increased expression of CYP2B6 protein CTD PMID:22733800 citral multiple interactions ISO RGD:1346751 6480464 [[CYP1A1 protein co-treated with CYP1B1 protein co-treated with CYP2B6 protein co-treated with CYP2E1 protein co-treated with CYP3A5 protein] results in increased metabolism of geraniol] which results in increased chemical synthesis of citral more ... CTD PMID:18611395 , PMID:18824010 clemizole increases expression ISO RGD:1346751 6480464 clemizole results in increased expression of CYP2B6 mRNA CTD PMID:31312845 clemizole multiple interactions ISO RGD:1346751 6480464 [clemizole co-treated with NR1I3 protein alternative form] results in increased expression of CYP2B6 mRNA, [clemizole co-treated with NR1I3 protein mutant form] results in increased expression of CYP2B6 mRNA CTD PMID:31312845 clofibrate multiple interactions ISO RGD:1624098 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of CYP2B9 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of CYP2B9 mRNA] CTD PMID:17585979 clofibrate decreases expression EXP 6480464 Clofibrate results in decreased expression of CYP2B3 mRNA CTD PMID:11328961 , PMID:18670166 clofibrate increases expression ISO RGD:1624098 6480464 Clofibrate results in increased expression of CYP2B9 mRNA CTD PMID:11356909 clofibrate affects expression EXP 6480464 Clofibrate affects the expression of CYP2B3 mRNA CTD PMID:19483382 clopidogrel multiple interactions ISO RGD:1346751 6480464 [Clopidogrel co-treated with NR1I3 protein mutant form] results in increased expression of CYP2B6 mRNA CTD PMID:31312845 clopidogrel increases expression ISO RGD:1346751 6480464 Clopidogrel results in increased expression of CYP2B6 mRNA CTD PMID:31312845 clopidogrel increases oxidation ISO RGD:1346751 6480464 CYP2B6 protein results in increased oxidation of clopidogrel CTD PMID:19812348 clorgyline decreases activity ISO RGD:1346751 6480464 Clorgyline results in decreased activity of CYP2B6 protein CTD PMID:25656918 clorgyline multiple interactions ISO RGD:1346751 6480464 Clorgyline inhibits the reaction [CYP2B6 protein results in increased hydroxylation of Bupropion] CTD PMID:25656918 clothianidin multiple interactions ISO RGD:1346751 6480464 [clothianidin co-treated with thiacloprid] results in increased expression of CYP2B6 protein CTD PMID:32201337 clotrimazole multiple interactions ISO RGD:1346751 6480464 Clotrimazole results in increased expression of and results in increased activity of CYP2B6 protein more ... CTD PMID:12695351 clotrimazole increases expression ISO RGD:1346751 6480464 Clotrimazole results in increased expression of CYP2B6 protein CTD PMID:12571232 , PMID:14977870 clotrimazole increases activity ISO RGD:1346751 6480464 Clotrimazole results in increased activity of CYP2B6 protein CTD PMID:14977870 cobalt dichloride increases expression ISO RGD:1624098 6480464 cobaltous chloride results in increased expression of CYP2B9 mRNA CTD PMID:23528251 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of CYP2B3 mRNA CTD PMID:24386269 copper atom multiple interactions ISO RGD:1624098 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of CYP2B9 mRNA CTD PMID:15467011 copper(0) multiple interactions ISO RGD:1624098 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of CYP2B9 mRNA CTD PMID:15467011 copper(II) chloride multiple interactions ISO RGD:1346751 6480464 [CYP2B6 protein co-treated with cupric chloride co-treated with NADP] results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone, [CYP2B6 protein co-treated with cupric chloride co-treated with NADP] results in increased metabolism of N'-nitrosonornicotine CTD PMID:32672941 copper(II) sulfate increases expression ISO RGD:1346751 6480464 Copper Sulfate results in increased expression of CYP2B6 mRNA CTD PMID:19549813 corticosterone multiple interactions ISO RGD:1346751 6480464 Corticosterone promotes the reaction [Ethanol results in increased expression of CYP2B6 mRNA] CTD PMID:35301062 corticosterone increases expression ISO RGD:1346751 6480464 Corticosterone results in increased expression of CYP2B6 mRNA, Corticosterone results in increased expression of CYP2B6 protein CTD PMID:35301062 cumene hydroperoxide affects oxidation EXP 6480464 CYP2B6 protein affects the oxidation of cumene hydroperoxide CTD PMID:17478480 cyclophosphamide increases metabolic processing ISO RGD:1346751 6480464 CYP2B6 protein results in increased metabolism of Cyclophosphamide CTD PMID:15769884 more ... cyclophosphamide increases activity EXP 6480464 CYP2B6 protein results in increased activity of Cyclophosphamide CTD PMID:11723234 cyclophosphamide affects hydroxylation ISO RGD:1346751 6480464 CYP2B6 intron polymorphism affects the hydroxylation of Cyclophosphamide, CYP2B6 promoter polymorphism affects the hydroxylation of Cyclophosphamide CTD PMID:17502835 cyclophosphamide increases response to substance ISO RGD:1346751 6480464 CYP2B6 protein results in increased susceptibility to Cyclophosphamide, CYP2B6 results in increased susceptibility to Cyclophosphamide CTD PMID:11389073 more ... cyclophosphamide increases hydroxylation ISO RGD:1346751 6480464 CYP2B6 protein results in increased hydroxylation of Cyclophosphamide CTD PMID:12872138 more ... cyclophosphamide multiple interactions ISO RGD:1346751 6480464 [Cyclophosphamide results in increased activity of NR1I3 protein alternative form] which results in increased expression of CYP2B6 mRNA more ... CTD PMID:10919648 more ... cyclosporin A decreases expression ISO RGD:1346751 6480464 Cyclosporine results in decreased expression of CYP2B6 mRNA CTD PMID:20106945 , PMID:32152650 cyclosporin A multiple interactions ISO RGD:1346751 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CYP2B6 mRNA CTD PMID:32152650 cyhalothrin increases expression ISO RGD:1346751 6480464 cyhalothrin results in increased expression of CYP2B6 mRNA CTD PMID:22310298 cyhalothrin multiple interactions ISO RGD:1346751 6480464 cyhalothrin inhibits the reaction [CYP2B6 protein results in increased hydroxylation of Bupropion] CTD PMID:22634058 cyhalothrin decreases activity ISO RGD:1346751 6480464 cyhalothrin results in decreased activity of CYP2B6 protein CTD PMID:22634058 cyhalothrin increases activity ISO RGD:1346751 6480464 cyhalothrin results in increased activity of CYP2B6 protein CTD PMID:22310298 cylindrospermopsin decreases activity ISO RGD:1346751 6480464 cylindrospermopsin results in decreased activity of CYP2B6 protein CTD PMID:30905859 cypermethrin increases activity ISO RGD:1346751 6480464 cypermethrin results in increased activity of CYP2B6 protein CTD PMID:22310298 cypermethrin increases expression ISO RGD:1346751 6480464 cypermethrin results in increased expression of CYP2B6 mRNA, cypermethrin results in increased expression of CYP2B6 protein CTD PMID:15548381 , PMID:22310298 cyproconazole increases expression ISO RGD:1624098 6480464 cyproconazole results in increased expression of CYP2B9 mRNA CTD PMID:22334560 cyproconazole increases expression ISO RGD:1346751 6480464 cyproconazole results in increased expression of CYP2B6 mRNA, cyproconazole results in increased expression of CYP2B6 protein CTD PMID:28058446 more ... cyproconazole multiple interactions ISO RGD:1346751 6480464 [cyproconazole co-treated with azoxystrobin] results in increased expression of CYP2B6 protein more ... CTD PMID:28058446 , PMID:29294346 cyproterone increases expression ISO RGD:1624098 6480464 Cyproterone results in increased expression of CYP2B9 mRNA CTD PMID:7771797 dapsone multiple interactions ISO RGD:1346751 6480464 CYP2B6 protein results in increased metabolism of and results in increased susceptibility to Dapsone CTD PMID:19998329 DDD increases expression ISO RGD:1346751 6480464 Dichlorodiphenyldichloroethane results in increased expression of CYP2B6 mRNA CTD PMID:20686338 DDE increases expression ISO RGD:1346751 6480464 Dichlorodiphenyl Dichloroethylene results in increased expression of CYP2B6 mRNA CTD PMID:20686338 DDE multiple interactions ISO RGD:1346751 6480464 [CYP2B6 gene SNP affects the susceptibility to DDT] which affects the abundance of Dichlorodiphenyl Dichloroethylene, CYP2B6 gene SNP affects the reaction [DDT results in increased abundance of Dichlorodiphenyl Dichloroethylene] CTD PMID:27839851 DDT increases expression ISO RGD:1346751 6480464 DDT results in increased expression of CYP2B6 mRNA, DDT results in increased expression of CYP2B6 protein CTD PMID:15548381 , PMID:20686338 DDT decreases expression EXP 6480464 DDT results in decreased expression of CYP2B3 mRNA CTD PMID:29477483 DDT multiple interactions ISO RGD:1346751 6480464 [CYP2B6 gene SNP affects the susceptibility to DDT] which affects the abundance of Dichlorodiphenyl Dichloroethylene, CYP2B6 gene SNP affects the reaction [DDT results in increased abundance of Dichlorodiphenyl Dichloroethylene] CTD PMID:27839851 Dechloroethylcyclophosphamide affects chemical synthesis ISO RGD:1346751 6480464 CYP2B6 protein affects the chemical synthesis of dechloroethylcyclophosphamide CTD PMID:15875221 deoxycholic acid increases expression ISO RGD:1346751 6480464 Deoxycholic Acid metabolite results in increased expression of CYP2B6 mRNA CTD PMID:27871908 deoxycholic acid multiple interactions ISO RGD:1346751 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CYP2B6 mRNA more ... CTD PMID:32152650 , PMID:33819548 dexamethasone increases expression ISO RGD:1624098 6480464 Dexamethasone results in increased expression of CYP2B9 mRNA CTD PMID:7771797 dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of CYP2B3 mRNA CTD PMID:11328961 dexamethasone increases expression ISO RGD:1346751 6480464 Dexamethasone results in increased expression of CYP2B6 mRNA, Dexamethasone results in increased expression of CYP2B6 protein CTD PMID:15548381 more ... dexamethasone multiple interactions ISO RGD:1346751 6480464 Dexamethasone promotes the reaction [NR3C1 protein affects the reaction [NR1I2 protein promotes the reaction [Clotrimazole results in increased expression of CYP2B6 mRNA]]] more ... CTD PMID:12695351 , PMID:15802389 diallyl disulfide increases expression ISO RGD:1346751 6480464 diallyl disulfide results in increased expression of CYP2B1 mRNA, diallyl disulfide results in increased expression of CYP2B2 mRNA CTD PMID:17353348 Diallyl sulfide increases expression ISO RGD:1346751 6480464 allyl sulfide results in increased expression of CYP2B1 mRNA more ... CTD PMID:17353348 diarylheptanoid decreases activity ISO RGD:1346751 6480464 Diarylheptanoids results in decreased activity of CYP2B6 protein CTD PMID:23850985 diarylheptanoid increases expression ISO RGD:1346751 6480464 Diarylheptanoids results in increased expression of CYP2B6 mRNA CTD PMID:23850985 diazinon multiple interactions ISO RGD:1346751 6480464 CYP2B6 protein results in decreased sulfation of and results in increased activity of Diazinon CTD PMID:15764407 diazinon affects metabolic processing ISO RGD:1346751 6480464 CYP2B6 protein affects the metabolism of Diazinon CTD PMID:15557345 , PMID:15764407 dibenz[a,h]anthracene increases metabolic processing ISO RGD:1346751 6480464 CYP2B6 protein results in increased metabolism of 1 more ... CTD PMID:8638931 dibenz[a,h]anthracene multiple interactions ISO RGD:1346751 6480464 [Benzo(a)pyrene co-treated with 1 more ... CTD PMID:17690111 , PMID:8638931 dichloroacetic acid increases expression ISO RGD:1624098 6480464 Dichloroacetic Acid results in increased expression of CYP2B9 mRNA CTD PMID:28962523 diclofenac increases expression ISO RGD:1624098 6480464 Diclofenac results in increased expression of CYP2B9 mRNA CTD PMID:26934552 dieldrin increases expression ISO RGD:1346751 6480464 Dieldrin results in increased expression of CYP2B6 protein CTD PMID:15548381 diethylstilbestrol increases expression ISO RGD:1346751 6480464 Diethylstilbestrol results in increased expression of CYP2B6 mRNA CTD PMID:21924250 difenoconazole increases expression ISO RGD:1346751 6480464 difenoconazole results in increased expression of CYP2B6 mRNA CTD PMID:33575850 difenoconazole multiple interactions ISO RGD:1346751 6480464 [difenoconazole co-treated with fludioxonil] results in increased expression of CYP2B6 mRNA CTD PMID:33575850 dimemorfan increases oxidation ISO RGD:1346751 6480464 CYP2B6 protein results in increased oxidation of dimemorfan CTD PMID:19593786 dimethyl sulfoxide increases expression ISO RGD:1346751 6480464 Dimethyl Sulfoxide results in increased expression of CYP2B6 mRNA, Dimethyl Sulfoxide results in increased expression of CYP2B6 protein CTD PMID:30262279 , PMID:31096615 dimethyl sulfoxide multiple interactions ISO RGD:1346751 6480464 [Dimethyl Sulfoxide co-treated with TGFB1 protein] results in decreased expression of CYP2B6 mRNA, [Dimethyl Sulfoxide co-treated with TGFB1 protein] results in decreased expression of CYP2B6 protein CTD PMID:35366062 diuron increases expression ISO RGD:1346751 6480464 Diuron results in increased expression of CYP2B6 mRNA CTD PMID:22310298 domperidone increases hydroxylation ISO RGD:1346751 6480464 CYP2B6 protein results in increased hydroxylation of Domperidone CTD PMID:15327587 doxorubicin multiple interactions ISO RGD:1346751 6480464 [Doxorubicin co-treated with Cyclophosphamide] affects the expression of CYP2B6 mRNA CTD PMID:16322899 dronedarone increases metabolic processing ISO RGD:1346751 6480464 CYP2B6 protein results in increased metabolism of dronedarone CTD PMID:29616291 efavirenz affects metabolic processing ISO RGD:1346751 6480464 CYP2B6 gene polymorphism affects the metabolism of efavirenz, CYP2B6 protein affects the metabolism of efavirenz CTD PMID:15622315 , PMID:17559344 efavirenz decreases activity ISO RGD:1346751 6480464 efavirenz results in decreased activity of CYP2B6 protein CTD PMID:26599973 efavirenz multiple interactions ISO RGD:1346751 6480464 [efavirenz results in decreased activity of CYP2B6 protein] which results in decreased metabolism of Bupropion more ... CTD PMID:17041008 , PMID:26599973 efavirenz increases metabolic processing ISO RGD:1346751 6480464 CYP2B6 protein results in increased metabolism of efavirenz CTD PMID:15769884 , PMID:17559344 elemental selenium increases expression ISO RGD:1624098 6480464 Selenium deficiency results in increased expression of CYP2B9 mRNA CTD PMID:16170372 endosulfan multiple interactions ISO RGD:1346751 6480464 [Atrazine co-treated with Chlorpyrifos co-treated with Endosulfan] results in increased expression of CYP2B6 mRNA more ... CTD PMID:16855053 more ... endosulfan increases activity ISO RGD:1346751 6480464 Endosulfan results in increased activity of CYP2B6 protein CTD PMID:24832206 endosulfan multiple interactions ISO RGD:1624098 6480464 [Atrazine co-treated with Chlorpyrifos co-treated with Endosulfan] results in decreased expression of CYP2B9 mRNA CTD PMID:22515965 endosulfan increases expression ISO RGD:1346751 6480464 Endosulfan results in increased expression of CYP2B6 mRNA, Endosulfan results in increased expression of CYP2B6 protein CTD PMID:15548381 more ... endosulfan affects metabolic processing ISO RGD:1346751 6480464 CYP2B6 protein affects the metabolism of Endosulfan CTD PMID:16581944 , PMID:16855053 endrin increases expression ISO RGD:1346751 6480464 Endrin results in increased expression of CYP2B6 protein CTD PMID:15548381 enilconazole affects expression ISO RGD:1346751 6480464 enilconazole affects the expression of CYP2B6 mRNA CTD PMID:32201337 enilconazole multiple interactions ISO RGD:1346751 6480464 [enilconazole co-treated with thiacloprid] results in increased expression of CYP2B6 protein more ... CTD PMID:32201337 epoxiconazole increases expression ISO RGD:1624098 6480464 epoxiconazole results in increased expression of CYP2B9 mRNA CTD PMID:22334560 , PMID:23970803 epoxiconazole decreases expression ISO RGD:1624098 6480464 epoxiconazole results in decreased expression of CYP2B9 mRNA CTD PMID:35436446 epoxiconazole multiple interactions ISO RGD:1346751 6480464 [fluxapyroxad co-treated with epoxiconazole] results in increased expression of CYP2B6 mRNA, [fluxapyroxad co-treated with epoxiconazole] results in increased expression of CYP2B6 protein CTD PMID:29294346 erlotinib hydrochloride increases expression ISO RGD:1346751 6480464 Erlotinib Hydrochloride results in increased expression of CYP2B6 mRNA CTD PMID:30364229 estrone increases expression ISO RGD:1624098 6480464 Estrone results in increased expression of CYP2B9 mRNA CTD PMID:7771797 ethanol increases expression ISO RGD:1624098 6480464 Ethanol results in increased expression of CYP2B9 mRNA CTD PMID:19167417 ethanol increases expression ISO RGD:1346751 6480464 Ethanol results in increased expression of CYP2B6 mRNA, Ethanol results in increased expression of CYP2B6 protein CTD PMID:35301062 ethanol multiple interactions ISO RGD:1346751 6480464 Corticosterone promotes the reaction [Ethanol results in increased expression of CYP2B6 mRNA] CTD PMID:35301062 farnesol multiple interactions ISO RGD:1346751 6480464 [Farnesol analog co-treated with Oleic Acid] results in increased expression of CYP2B6 mRNA, Farnesol analog inhibits the reaction [Oleic Acid results in decreased expression of CYP2B6 mRNA] CTD PMID:30611723 farnesol increases expression ISO RGD:1346751 6480464 Farnesol analog results in increased expression of CYP2B6 mRNA, Farnesol results in increased expression of CYP2B6 mRNA CTD PMID:30611723 felodipine increases expression ISO RGD:1346751 6480464 Felodipine results in increased expression of CYP2B6 mRNA, Felodipine results in increased expression of CYP2B6 protein CTD PMID:27732883 fenitrothion increases expression ISO RGD:1346751 6480464 Fenitrothion results in increased expression of CYP2B6 mRNA CTD PMID:22310298 fenitrothion decreases activity ISO RGD:1346751 6480464 Fenitrothion results in decreased activity of CYP2B6 protein CTD PMID:20183062 more ... fenitrothion multiple interactions ISO RGD:1346751 6480464 Fenitrothion inhibits the reaction [CYP2B6 protein results in increased hydroxylation of Bupropion] CTD PMID:22634058 fenofibrate increases expression ISO RGD:1624098 6480464 Fenofibrate results in increased expression of CYP2B9 mRNA CTD PMID:11798191 fenproporex decreases alkylation ISO RGD:1346751 6480464 CYP2B6 protein results in decreased alkylation of fenproporex CTD PMID:15294457 fenvalerate increases activity ISO RGD:1346751 6480464 fenvalerate results in increased activity of CYP2B6 protein CTD PMID:22310298 fenvalerate decreases activity ISO RGD:1346751 6480464 fenvalerate results in decreased activity of CYP2B6 protein CTD PMID:22634058 fenvalerate multiple interactions ISO RGD:1346751 6480464 fenvalerate inhibits the reaction [CYP2B6 protein results in increased hydroxylation of Bupropion] CTD PMID:22634058 fenvalerate increases expression ISO RGD:1346751 6480464 fenvalerate results in increased expression of CYP2B6 mRNA, fenvalerate results in increased expression of CYP2B6 protein CTD PMID:15548381 , PMID:22310298 finasteride increases expression EXP 6480464 Finasteride results in increased expression of CYP2B3 protein CTD PMID:27750143 fipronil multiple interactions ISO RGD:1346751 6480464 [fipronil co-treated with DEET] results in increased expression of CYP2B6 mRNA CTD PMID:27091632 fipronil increases expression ISO RGD:1346751 6480464 fipronil results in increased expression of CYP2B6 mRNA CTD PMID:17084830 , PMID:27091632 flavonoids decreases expression EXP 6480464 Flavonoids results in decreased expression of CYP2B6 mRNA CTD PMID:18035473 fludioxonil multiple interactions ISO RGD:1346751 6480464 [difenoconazole co-treated with fludioxonil] results in increased expression of CYP2B6 mRNA more ... CTD PMID:33575850 fludioxonil increases expression ISO RGD:1346751 6480464 fludioxonil results in increased expression of CYP2B6 mRNA CTD PMID:33575850 fluoranthene increases expression ISO RGD:1346751 6480464 fluoranthene results in increased expression of CYP2B6 mRNA CTD PMID:33249052 fluoranthene multiple interactions ISO RGD:1346751 6480464 [fluoranthene co-treated with Benzo(a)pyrene] inhibits the reaction [pyrene results in increased expression of CYP2B6 mRNA] more ... CTD PMID:33249052 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of CYP2B3 mRNA CTD PMID:24136188 flutamide increases expression EXP 6480464 Flutamide results in increased expression of CYP2B3 mRNA CTD PMID:24793618 fluvastatin increases expression ISO RGD:1346751 6480464 fluvastatin results in increased expression of CYP2B6 mRNA CTD PMID:15802384 fluxapyroxad increases expression ISO RGD:1346751 6480464 fluxapyroxad results in increased expression of CYP2B6 mRNA, fluxapyroxad results in increased expression of CYP2B6 protein CTD PMID:29294346 fluxapyroxad multiple interactions ISO RGD:1346751 6480464 [fluxapyroxad co-treated with epoxiconazole] results in increased expression of CYP2B6 mRNA, [fluxapyroxad co-treated with epoxiconazole] results in increased expression of CYP2B6 protein CTD PMID:29294346 folic acid multiple interactions ISO RGD:1624098 6480464 [Choline deficiency co-treated with Folic Acid deficiency co-treated with Methionine deficiency] results in increased expression of CYP2B9 mRNA, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CYP2B9 mRNA CTD PMID:20938992 , PMID:29127188 furathiocarb increases activity ISO RGD:1346751 6480464 deltanit results in increased activity of CYP2B6 protein CTD PMID:22310298 furathiocarb increases expression ISO RGD:1346751 6480464 deltanit results in increased expression of CYP2B6 mRNA CTD PMID:22310298 galangin increases expression ISO RGD:1346751 6480464 galangin results in increased expression of CYP2B6 mRNA CTD PMID:25625231 gamma-hexachlorocyclohexane increases expression ISO RGD:1346751 6480464 Hexachlorocyclohexane results in increased expression of CYP2B6 mRNA, Hexachlorocyclohexane results in increased expression of CYP2B6 protein CTD PMID:15548381 , PMID:20035023 geranial multiple interactions ISO RGD:1346751 6480464 [[CYP1A1 protein co-treated with CYP1B1 protein co-treated with CYP2B6 protein co-treated with CYP2E1 protein co-treated with CYP3A5 protein] results in increased metabolism of geraniol] which results in increased chemical synthesis of citral more ... CTD PMID:18611395 , PMID:18824010 geraniol multiple interactions ISO RGD:1346751 6480464 [[CYP1A1 protein co-treated with CYP1B1 protein co-treated with CYP2B6 protein co-treated with CYP2E1 protein co-treated with CYP3A5 protein] results in increased metabolism of geraniol] which results in increased chemical synthesis of citral more ... CTD PMID:18611395 , PMID:18824010 geraniol increases metabolic processing ISO RGD:1346751 6480464 CYP2B6 protein results in increased metabolism of geraniol CTD PMID:18824010 Ginkgolide A increases expression ISO RGD:1346751 6480464 ginkgolide A results in increased expression of CYP2B6 mRNA CTD PMID:19034627 ginkgolide B increases expression ISO RGD:1346751 6480464 ginkgolide B results in increased expression of CYP2B6 mRNA CTD PMID:19034627 glutathione multiple interactions ISO RGD:1346751 6480464 [CYP2B6 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 2'-(glutathion-S-yl)-deschlorodiclofenac more ... CTD PMID:24246759 , PMID:32198085 glycochenodeoxycholic acid multiple interactions ISO RGD:1346751 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CYP2B6 mRNA more ... CTD PMID:32152650 , PMID:33819548 glycocholic acid multiple interactions ISO RGD:1346751 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CYP2B6 mRNA more ... CTD PMID:32152650 , PMID:33819548 glycodeoxycholic acid multiple interactions ISO RGD:1346751 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CYP2B6 mRNA more ... CTD PMID:32152650 , PMID:33819548 griseofulvin affects expression ISO RGD:1624098 6480464 Griseofulvin affects the expression of CYP2B9 mRNA CTD PMID:12735108 GW 3965 multiple interactions ISO RGD:1346751 6480464 GW 3965 inhibits the reaction [6-(4-chlorophenyl)imidazo(2 more ... CTD PMID:23732298 GW 4064 multiple interactions ISO RGD:1346751 6480464 [GW 4064 co-treated with Oleic Acid] results in decreased expression of CYP2B6 mRNA CTD PMID:30611723 GW 4064 decreases expression ISO RGD:1346751 6480464 GW 4064 results in decreased expression of CYP2B6 mRNA CTD PMID:30611723 GW 7647 multiple interactions ISO RGD:1346751 6480464 [GW 7647 co-treated with Oleic Acid] results in decreased expression of CYP2B6 mRNA CTD PMID:30611723 GW 7647 increases expression ISO RGD:1346751 6480464 GW 7647 results in increased expression of CYP2B6 mRNA CTD PMID:31676336 halothane increases metabolic processing ISO RGD:1346751 6480464 CYP2B6 protein results in increased metabolism of Halothane CTD PMID:11684365 helenalin increases oxidation ISO RGD:1346751 6480464 CYP2B6 protein results in increased oxidation of helenalin CTD PMID:34989853 herbicide multiple interactions ISO RGD:1346751 6480464 [CYP1A1 protein co-treated with CYP2B6 protein co-treated with CYP2C19 protein] results in decreased susceptibility to Herbicides CTD PMID:16608219 hexaflumuron increases activity ISO RGD:1346751 6480464 hexafluoron results in increased activity of CYP2B6 protein CTD PMID:22310298 hexaflumuron increases expression ISO RGD:1346751 6480464 hexafluoron results in increased expression of CYP2B6 mRNA CTD PMID:22310298 hexane increases hydroxylation ISO RGD:1346751 6480464 CYP2B1 protein results in increased hydroxylation of n-hexane, CYP2B6 protein results in increased hydroxylation of n-hexane CTD PMID:16484137 hydroquinone affects response to substance ISO RGD:1346751 6480464 CYP2B1 protein affects the susceptibility to hydroquinone CTD PMID:8242868 Hydroxybupropion increases chemical synthesis ISO RGD:1346751 6480464 CYP2B6 protein results in increased chemical synthesis of hydroxybupropion CTD PMID:21915887 , PMID:23850985 Hydroxybupropion multiple interactions ISO RGD:1346751 6480464 [CYP2B6 protein results in increased hydroxylation of Bupropion] which results in increased chemical synthesis of hydroxybupropion more ... CTD PMID:21915887 more ... hyperforin increases expression ISO RGD:1346751 6480464 hyperforin results in increased expression of CYP2B6 mRNA CTD PMID:24259679 ifosfamide increases response to substance ISO RGD:1346751 6480464 CYP2B6 results in increased susceptibility to Ifosfamide CTD PMID:9766669 ifosfamide affects metabolic processing ISO RGD:1346751 6480464 CYP2B6 protein affects the metabolism of Ifosfamide CTD PMID:15875221 ifosfamide multiple interactions ISO RGD:1346751 6480464 POR promotes the reaction [CYP2B6 results in increased susceptibility to Ifosfamide] CTD PMID:9766669 imidazoles multiple interactions ISO RGD:1346751 6480464 Imidazoles inhibits the reaction [6-(4-chlorophenyl)imidazo(2 more ... CTD PMID:21778469 imipramine oxide increases abundance ISO RGD:1346751 6480464 CYP2B6 protein results in increased abundance of imipramine N-oxide CTD PMID:27320963 indometacin decreases expression EXP 6480464 Indomethacin results in decreased expression of CYP2B3 mRNA, Indomethacin results in decreased expression of CYP2B6 mRNA CTD PMID:16771604 isoimperatorin increases oxidation ISO RGD:1346751 6480464 CYP2B6 protein results in increased oxidation of isoimperatorin CTD PMID:25500267 isoimperatorin multiple interactions ISO RGD:1346751 6480464 [isoimperatorin co-treated with NADP] results in decreased activity of CYP2B6 protein, Mephenytoin inhibits the reaction [[isoimperatorin co-treated with NADP] results in decreased activity of CYP2B6 protein] CTD PMID:25500267 isoproturon increases activity ISO RGD:1346751 6480464 isoproturon results in increased activity of CYP2B6 protein CTD PMID:22310298 isoproturon increases expression ISO RGD:1346751 6480464 isoproturon results in increased expression of CYP2B6 mRNA CTD PMID:22310298 isoxazoles increases expression ISO RGD:1346751 6480464 Isoxazoles analog results in increased expression of CYP2B6 mRNA CTD PMID:21924250 isoxazoles affects activity ISO RGD:1346751 6480464 Isoxazoles analog affects the activity of CYP2B6 protein CTD PMID:21924250 Isradipine increases expression ISO RGD:1346751 6480464 Isradipine results in increased expression of CYP2B6 mRNA, Isradipine results in increased expression of CYP2B6 protein CTD PMID:27732883 ketoconazole decreases activity ISO RGD:1346751 6480464 Ketoconazole results in decreased activity of CYP2B6 protein CTD PMID:14709627 ketoconazole multiple interactions ISO RGD:1346751 6480464 Ketoconazole inhibits the reaction [6-(4-chlorophenyl)imidazo(2 more ... CTD PMID:16608920 , PMID:17438109 kojic acid multiple interactions ISO RGD:1624098 6480464 [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CYP2B9 mRNA CTD PMID:17917374 L-ascorbic acid multiple interactions ISO RGD:1624098 6480464 [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CYP2B9 mRNA CTD PMID:17917374 L-ethionine affects expression EXP 6480464 Ethionine affects the expression of CYP2B3 mRNA CTD PMID:19483382 L-methionine multiple interactions ISO RGD:1624098 6480464 [Choline deficiency co-treated with Folic Acid deficiency co-treated with Methionine deficiency] results in increased expression of CYP2B9 mRNA, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CYP2B9 mRNA CTD PMID:20938992 , PMID:29127188 lactacystin multiple interactions ISO RGD:1346751 6480464 lactacystin inhibits the reaction [6-(4-chlorophenyl)imidazo(2 more ... CTD PMID:24224465 lamotrigine increases glutathionylation ISO RGD:1346751 6480464 CYP2B6 protein results in increased glutathionylation of lamotrigine CTD PMID:19961160 lead diacetate increases expression ISO RGD:1624098 6480464 lead acetate results in increased expression of CYP2B9 mRNA CTD PMID:21335049 lefetamine decreases alkylation ISO RGD:1346751 6480464 CYP2B6 protein results in decreased alkylation of lephetamine CTD PMID:26276083 leflunomide increases expression ISO RGD:1346751 6480464 Leflunomide results in increased expression of CYP2B6 mRNA CTD PMID:30364229 lycopene multiple interactions ISO RGD:1624098 6480464 lycopene affects the reaction [Atrazine results in increased expression of CYP2B9 mRNA] CTD PMID:26775023 malathion increases expression ISO RGD:1346751 6480464 Malathion results in increased expression of CYP2B6 mRNA CTD PMID:22310298 malathion multiple interactions ISO RGD:1346751 6480464 Malathion promotes the reaction [isomalathion results in increased expression of CYP2B6 mRNA] CTD PMID:24333466 malathion affects metabolic processing ISO RGD:1346751 6480464 CYP2B6 protein affects the metabolism of Malathion CTD PMID:15557345 malathion decreases activity ISO RGD:1346751 6480464 Malathion results in decreased activity of CYP2B6 protein CTD PMID:22310298 mancozeb decreases expression ISO RGD:1346751 6480464 mancozeb results in decreased expression of CYP2B6 protein CTD PMID:31096615 Meclizine multiple interactions ISO RGD:1346751 6480464 Meclizine inhibits the reaction [[Phenobarbital results in increased activity of NR1I3 protein] which results in increased expression of CYP2B10 mRNA] CTD PMID:15272053 mefenacet multiple interactions ISO RGD:1346751 6480464 CYP2B6 protein results in increased metabolism of and results in decreased susceptibility to mefenacet CTD PMID:15853388 mephenytoin increases metabolic processing ISO RGD:1346751 6480464 CYP2B6 protein results in increased metabolism of Mephenytoin CTD PMID:12464242 mephenytoin multiple interactions ISO RGD:1346751 6480464 Mephenytoin inhibits the reaction [[isoimperatorin co-treated with NADP] results in decreased activity of CYP2B6 protein] more ... CTD PMID:25500267 , PMID:9241656 mephenytoin decreases activity ISO RGD:1346751 6480464 Mephenytoin results in decreased activity of CYP2B6 protein CTD PMID:9241656 mephenytoin decreases methylation ISO RGD:1346751 6480464 CYP2B6 protein results in decreased methylation of Mephenytoin CTD PMID:12433797 mercury dichloride increases expression ISO RGD:1624098 6480464 Mercuric Chloride results in increased expression of CYP2B9 mRNA CTD PMID:24472606 metazachlor increases expression ISO RGD:1346751 6480464 metazachlor results in increased expression of CYP2B6 mRNA CTD PMID:31465819 metformin multiple interactions ISO RGD:1624098 6480464 Metformin promotes the reaction [Streptozocin results in increased expression of CYP2B9 mRNA] CTD PMID:22342832 methiocarb increases metabolic processing ISO RGD:1346751 6480464 CYP2B6 protein results in increased metabolism of Methiocarb CTD PMID:27665777 methiocarb multiple interactions ISO RGD:1346751 6480464 [CYP2B6 protein results in increased metabolism of Methiocarb] which results in increased abundance of methiocarb sulfoxide CTD PMID:27665777 methiocarb-sulfoxide multiple interactions ISO RGD:1346751 6480464 [CYP2B6 protein results in increased metabolism of Methiocarb] which results in increased abundance of methiocarb sulfoxide CTD PMID:27665777 methiocarb-sulfoxide increases abundance ISO RGD:1346751 6480464 CYP2B6 protein results in increased abundance of methiocarb sulfoxide CTD PMID:27665777 methoxychlor increases hydroxylation ISO RGD:1346751 6480464 CYP2B6 protein results in increased hydroxylation of Methoxychlor CTD PMID:10101147 more ... methoxychlor increases activity ISO RGD:1346751 6480464 Methoxychlor results in increased activity of CYP2B6 protein CTD PMID:24832206 methoxychlor decreases activity ISO RGD:1346751 6480464 Methoxychlor results in decreased activity of CYP2B6 protein CTD PMID:9241656 methoxychlor multiple interactions ISO RGD:1346751 6480464 [Endosulfan co-treated with Methoxychlor] results in decreased activity of CYP2B6 protein more ... CTD PMID:10037683 more ... methoxychlor decreases methylation ISO RGD:1346751 6480464 CYP2B6 protein results in decreased methylation of Methoxychlor CTD PMID:12167570 more ... methoxychlor increases metabolic processing ISO RGD:1346751 6480464 CYP2B6 protein results in increased metabolism of Methoxychlor CTD PMID:12464242 methoxychlor increases expression ISO RGD:1346751 6480464 Methoxychlor results in increased expression of CYP2B6 mRNA, Methoxychlor results in increased expression of CYP2B6 protein CTD PMID:15548381 more ... methoxyflurane increases metabolic processing ISO RGD:1346751 6480464 CYP2B6 protein results in increased metabolism of Methoxyflurane CTD PMID:7879937 methylisothiazolinone increases expression ISO RGD:1346751 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of CYP2B6 mRNA CTD PMID:31629900 metolachlor multiple interactions ISO RGD:1346751 6480464 [CYP1A1 protein co-treated with CYP2B6 protein co-treated with CYP2C19 protein] results in decreased susceptibility to [norflurazone co-treated with metolachlor co-treated with Atrazine] more ... CTD PMID:15853388 more ... metolachlor increases metabolic processing ISO RGD:1346751 6480464 CYP2B6 protein results in increased metabolism of metolachlor CTD PMID:11133395 mifepristone multiple interactions ISO RGD:1346751 6480464 [Mifepristone results in increased activity of NR1I3 protein alternative form] which results in increased expression of CYP2B6 mRNA CTD PMID:17041008 Mitotane increases expression ISO RGD:1346751 6480464 Mitotane results in increased expression of CYP2B6 mRNA CTD PMID:31312845 Mitotane affects abundance ISO RGD:1346751 6480464 CYP2B6 gene polymorphism affects the abundance of Mitotane, CYP2B6 protein affects the abundance of Mitotane CTD PMID:23524664 Mitotane multiple interactions ISO RGD:1346751 6480464 [Mitotane co-treated with NR1I3 protein alternative form] results in increased expression of CYP2B6 mRNA, [Mitotane co-treated with NR1I3 protein mutant form] results in increased expression of CYP2B6 mRNA CTD PMID:31312845 monocrotaline multiple interactions ISO RGD:1624098 6480464 [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of CYP2B9 mRNA CTD PMID:21224054 monocrotophos multiple interactions ISO RGD:1346751 6480464 [Monocrotophos co-treated with Cimetidine] results in increased expression of CYP2B6 protein more ... CTD PMID:22733800 monocrotophos increases activity ISO RGD:1346751 6480464 Monocrotophos results in increased activity of CYP2B6 protein CTD PMID:22733800 monocrotophos increases expression ISO RGD:1346751 6480464 Monocrotophos results in increased expression of CYP2B6 mRNA, Monocrotophos results in increased expression of CYP2B6 protein CTD PMID:22733800 monosodium L-glutamate increases expression ISO RGD:1624098 6480464 Sodium Glutamate results in increased expression of CYP2B9 mRNA CTD PMID:19001666 , PMID:20111022 monosodium L-glutamate multiple interactions ISO RGD:1624098 6480464 [Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of CYP2B9 mRNA, [Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of CYP2B9 mRNA CTD PMID:19001666 , PMID:20111022 moricizine increases expression ISO RGD:1346751 6480464 Moricizine results in increased expression of CYP2B6 mRNA CTD PMID:18332078 N'-Nitrosonornicotine multiple interactions ISO RGD:1346751 6480464 [CYP2B6 protein co-treated with cupric chloride co-treated with NADP] results in increased metabolism of N'-nitrosonornicotine CTD PMID:32672941 N,N-diethyl-m-toluamide multiple interactions ISO RGD:1346751 6480464 [fipronil co-treated with DEET] results in increased expression of CYP2B6 mRNA, Chlorpyrifos inhibits the reaction [CYP2B6 protein results in increased metabolism of DEET] CTD PMID:11854147 , PMID:27091632 N,N-diethyl-m-toluamide increases expression ISO RGD:1346751 6480464 DEET results in increased expression of CYP2B6 mRNA CTD PMID:19326769 more ... N,N-diethyl-m-toluamide increases metabolic processing ISO RGD:1346751 6480464 CYP2B6 protein results in increased metabolism of DEET CTD PMID:11854147 N,N-diisopropyltryptamine decreases activity ISO RGD:1346751 6480464 N, N-diisopropyltryptamine analog results in decreased activity of CYP2B6 protein CTD PMID:26599973 N,N-diisopropyltryptamine multiple interactions ISO RGD:1346751 6480464 [N, N-diisopropyltryptamine analog results in decreased activity of CYP2B6 protein] which results in decreased metabolism of Bupropion CTD PMID:26599973 N-[3-(aminomethyl)benzyl]acetamidine multiple interactions ISO RGD:1346751 6480464 N-(3-(aminomethyl)benzyl)acetamidine inhibits the reaction [Phenytoin results in increased expression of CYP2B6 mRNA] CTD PMID:18206661 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:1346751 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [6-(4-chlorophenyl)imidazo(2 more ... CTD PMID:24224465 N-Nitrosodi-n-propylamine affects metabolic processing ISO RGD:1346751 6480464 CYP2B6 protein affects the metabolism of N-nitroso(di-n-propyl)amine CTD PMID:10910959 N-nitrosodiethylamine multiple interactions ISO RGD:1624098 6480464 [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CYP2B9 mRNA, [Diethylnitrosamine co-treated with Piperonyl Butoxide] results in increased expression of CYP2B9 mRNA CTD PMID:17917374 , PMID:19690152 N-nitrosodiethylamine increases expression ISO RGD:1624098 6480464 Diethylnitrosamine results in increased expression of CYP2B9 mRNA CTD PMID:24535843 NADP zwitterion multiple interactions ISO RGD:1346751 6480464 [CYP2B6 protein co-treated with cupric chloride co-treated with NADP] results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone more ... CTD PMID:11805216 more ... NADP(+) multiple interactions ISO RGD:1346751 6480464 [CYP2B6 protein co-treated with cupric chloride co-treated with NADP] results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone more ... CTD PMID:11805216 more ... nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of CYP2B3 mRNA CTD PMID:24136188 nefazodone multiple interactions ISO RGD:1346751 6480464 [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CYP2B6 mRNA CTD PMID:32152650 nefazodone decreases expression ISO RGD:1346751 6480464 nefazodone results in decreased expression of CYP2B6 mRNA CTD PMID:32152650 nevirapine multiple interactions ISO RGD:1346751 6480464 [Nevirapine results in increased activity of NR1I3 protein alternative form] which results in increased expression of CYP2B6 mRNA, [Nevirapine results in increased activity of NR1I3 protein] which results in increased expression of CYP2B6 mRNA CTD PMID:17041008 nickel sulfate decreases expression ISO RGD:1624098 6480464 nickel sulfate results in decreased expression of CYP2B9 mRNA CTD PMID:16100012 nicotine increases metabolic processing ISO RGD:1346751 6480464 CYP2B6 protein results in increased metabolism of Nicotine CTD PMID:12488541 nicotine increases oxidation ISO RGD:1346751 6480464 CYP2B6 protein results in increased oxidation of Nicotine CTD PMID:30906561 nicotine affects oxidation ISO RGD:1346751 6480464 CYP2B6 gene polymorphism affects the oxidation of Nicotine CTD PMID:30906561 nicotine multiple interactions ISO RGD:1346751 6480464 CYP2B6 gene polymorphism affects the reaction [CYP2A6 protein results in increased metabolism of Nicotine] CTD PMID:18004205 Nicotine imine increases chemical synthesis ISO RGD:1346751 6480464 CYP2B6 protein results in increased chemical synthesis of nicotine imine CTD PMID:30906561 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of CYP2B3 mRNA CTD PMID:24136188 nimesulide increases glutathionylation ISO RGD:1346751 6480464 CYP2B6 protein results in increased glutathionylation of nimesulide CTD PMID:26524229 Nonylphenol increases metabolic processing ISO RGD:1346751 6480464 CYP2B6 results in increased metabolism of nonylphenol CTD PMID:9817083 norflurazon multiple interactions ISO RGD:1346751 6480464 [CYP1A1 protein co-treated with CYP2B6 protein co-treated with CYP2C19 protein] results in decreased susceptibility to [norflurazone co-treated with metolachlor co-treated with Atrazine] more ... CTD PMID:15853388 , PMID:16608219 Notopterol decreases activity ISO RGD:1346751 6480464 notopterol results in decreased activity of CYP2B6 protein CTD PMID:32198085 Notopterol increases metabolic processing ISO RGD:1346751 6480464 CYP2B6 protein results in increased metabolism of notopterol CTD PMID:32198085 Notopterol multiple interactions ISO RGD:1346751 6480464 [CYP2B6 protein results in increased metabolism of notopterol] promotes the reaction [Glutathione binds to notopterol] more ... CTD PMID:32198085 o-anisidine increases oxidation ISO RGD:1346751 6480464 CYP2B6 protein results in increased oxidation of 2-anisidine CTD PMID:15828049 O-methyleugenol decreases expression ISO RGD:1346751 6480464 methyleugenol results in decreased expression of CYP2B6 mRNA CTD PMID:32234424 ochratoxin A decreases expression ISO RGD:1346751 6480464 ochratoxin A results in decreased expression of CYP2B6 mRNA CTD PMID:26505656 ochratoxin A increases expression ISO RGD:1346751 6480464 ochratoxin A results in increased expression of CYP2B6 mRNA CTD PMID:21834667 , PMID:26505656 oleic acid multiple interactions ISO RGD:1346751 6480464 [6-(4-chlorophenyl)imidazo(2 more ... CTD PMID:24534255 , PMID:30611723 oleic acid decreases expression ISO RGD:1346751 6480464 Oleic Acid results in decreased expression of CYP2B6 mRNA CTD PMID:30611723 oltipraz decreases activity ISO RGD:1346751 6480464 oltipraz results in decreased activity of CYP2B6 protein CTD PMID:19833192 oltipraz increases expression ISO RGD:1346751 6480464 oltipraz results in increased expression of CYP2B6 mRNA, oltipraz results in increased expression of CYP2B6 protein CTD PMID:19833192 omeprazole affects expression EXP 6480464 Omeprazole affects the expression of CYP2B3 mRNA CTD PMID:19483382 omeprazole increases activity ISO RGD:1346751 6480464 Omeprazole results in increased activity of CYP2B6 protein CTD PMID:19118567 omeprazole increases expression ISO RGD:1346751 6480464 Omeprazole results in increased expression of CYP2B6 mRNA CTD PMID:17954527 more ... orphenadrine decreases activity ISO RGD:1346751 6480464 Orphenadrine results in decreased activity of CYP2B6 protein CTD PMID:12464242 more ... orphenadrine multiple interactions ISO RGD:1346751 6480464 Orphenadrine inhibits the reaction [CYP2B6 protein results in decreased ethylation of 7-ethoxy-4-trifluoromethylcoumarin], Orphenadrine inhibits the reaction [CYP2B6 protein results in increased chemical synthesis of 7-hydroxy-4-trifluoromethylcoumarin] CTD PMID:9241656 oxybenzone decreases expression EXP 6480464 oxybenzone results in decreased expression of CYP2B3 mRNA CTD PMID:30316929 p-menthan-3-ol multiple interactions ISO RGD:1346751 6480464 Menthol inhibits the reaction [CYP2B6 protein results in increased hydrolysis of Bupropion] CTD PMID:18611395 paracetamol multiple interactions ISO RGD:1624098 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of CYP2B9 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of CYP2B9 mRNA] CTD PMID:17585979 paracetamol multiple interactions ISO RGD:1346751 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of CYP2B6 mRNA CTD PMID:33819548 paracetamol decreases expression ISO RGD:1346751 6480464 Acetaminophen results in decreased expression of CYP2B6 mRNA CTD PMID:29067470 parathion affects metabolic processing ISO RGD:1346751 6480464 CYP2B6 protein affects the metabolism of Parathion CTD PMID:15557345 , PMID:17079358 parathion increases expression ISO RGD:1346751 6480464 Parathion results in increased expression of CYP2B6 mRNA CTD PMID:26196221 parathion decreases sulfation ISO RGD:1346751 6480464 CYP2B6 protein results in decreased sulfation of Parathion CTD PMID:17079358 Pargyline multiple interactions ISO RGD:1346751 6480464 Pargyline inhibits the reaction [CYP2B6 protein results in increased hydroxylation of Bupropion] CTD PMID:25656918 Pargyline decreases activity ISO RGD:1346751 6480464 Pargyline results in decreased activity of CYP2B6 protein CTD PMID:25656918 paricalcitol multiple interactions ISO RGD:1346751 6480464 [Phosphorus co-treated with paricalcitol] results in decreased expression of CYP2B6 mRNA CTD PMID:17715259 paroxetine multiple interactions ISO RGD:1346751 6480464 Paroxetine inhibits the reaction [CYP2B6 protein results in increased chemical synthesis of hydroxybupropion], Paroxetine inhibits the reaction [CYP2B6 protein results in increased metabolism of Bupropion] CTD PMID:21915887 paroxetine decreases activity ISO RGD:1346751 6480464 Paroxetine results in decreased activity of CYP2B6 protein CTD PMID:21915887 pazopanib increases expression ISO RGD:1346751 6480464 pazopanib results in increased expression of CYP2B6 mRNA CTD PMID:29356861 PCB138 multiple interactions ISO RGD:1624098 6480464 [2 more ... CTD PMID:25510870 pencycuron affects binding ISO RGD:1346751 6480464 pencycuron binds to CYP2B6 protein CTD PMID:32278787 pendimethalin multiple interactions ISO RGD:1346751 6480464 CYP2B6 protein results in increased metabolism of and results in decreased susceptibility to pendimethalin CTD PMID:15853388 pentachlorophenol increases expression ISO RGD:1346751 6480464 Pentachlorophenol results in increased expression of CYP2B6 protein CTD PMID:15548381 perflubutane increases expression ISO RGD:1346751 6480464 perfluorobutane results in increased expression of CYP2B6 mRNA CTD PMID:23567314 perfluorobutanesulfonic acid increases expression ISO RGD:1346751 6480464 perfluorobutanesulfonic acid results in increased expression of CYP2B6 mRNA CTD PMID:35337807 perfluorodecanoic acid increases expression ISO RGD:1346751 6480464 perfluorodecanoic acid results in increased expression of CYP2B6 mRNA CTD PMID:23567314 , PMID:35337807 perfluoroheptanoic acid increases expression ISO RGD:1346751 6480464 perfluoro-n-heptanoic acid results in increased expression of CYP2B6 mRNA CTD PMID:23567314 , PMID:35337807 perfluorohexanesulfonic acid increases expression ISO RGD:1346751 6480464 perfluorohexanesulfonic acid results in increased expression of CYP2B6 mRNA CTD PMID:23567314 , PMID:35337807 perfluorohexanoic acid increases expression ISO RGD:1346751 6480464 perfluorohexanoic acid results in increased expression of CYP2B6 mRNA CTD PMID:23567314 , PMID:35337807 perfluorononanoic acid increases expression ISO RGD:1346751 6480464 perfluoro-n-nonanoic acid results in increased expression of CYP2B6 mRNA CTD PMID:23567314 perfluorooctane-1-sulfonic acid affects expression EXP 6480464 perfluorooctane sulfonic acid affects the expression of CYP2B3 mRNA CTD PMID:17383973 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1624098 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CYP2B9 mRNA, [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of CYP2B9 mRNA CTD PMID:36331819 perfluorooctane-1-sulfonic acid increases expression ISO RGD:1346751 6480464 perfluorooctane sulfonic acid results in increased expression of CYP2B6 mRNA CTD PMID:21723365 more ... perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1346751 6480464 perfluorooctane sulfonic acid inhibits the reaction [CYP2B6 protein results in increased oxidation of 7-ethoxy-4-trifluoromethylcoumarin] CTD PMID:21964418 perfluorooctanoic acid affects expression EXP 6480464 perfluorooctanoic acid affects the expression of CYP2B3 mRNA CTD PMID:17383973 perfluorooctanoic acid increases expression ISO RGD:1346751 6480464 perfluorooctanoic acid results in increased expression of CYP2B6 mRNA CTD PMID:23567314 more ... perfluorooctanoic acid multiple interactions ISO RGD:1624098 6480464 PPARA protein promotes the reaction [perfluorooctanoic acid results in increased expression of CYP2B9 mRNA] CTD PMID:18281256 perfluorooctanoic acid increases expression ISO RGD:1624098 6480464 perfluorooctanoic acid results in increased expression of CYP2B9 mRNA CTD PMID:18281256 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of CYP2B3 mRNA CTD PMID:19162173 perillyl aldehyde multiple interactions ISO RGD:1346751 6480464 perillaldehyde inhibits the reaction [CYP2B6 protein results in increased hydrolysis of Bupropion] CTD PMID:18611395 permethrin increases expression ISO RGD:1346751 6480464 Permethrin results in increased expression of CYP2B6 mRNA CTD PMID:19326768 permethrin multiple interactions ISO RGD:1346751 6480464 [Permethrin co-treated with NR1I3 protein mutant form] results in increased expression of CYP2B6 mRNA CTD PMID:31312845 permethrin affects activity ISO RGD:1346751 6480464 Permethrin affects the activity of CYP2B6 protein CTD PMID:21924250 phenanthrene increases expression ISO RGD:1346751 6480464 phenanthrene results in increased expression of CYP2B6 mRNA CTD PMID:31181217 phencyclidine decreases activity ISO RGD:1346751 6480464 Phencyclidine analog results in decreased activity of CYP2B6 protein, Phencyclidine results in decreased activity of CYP2B6 protein CTD PMID:16782764 phencyclidine affects oxidation ISO RGD:1346751 6480464 CYP2B6 protein affects the oxidation of Phencyclidine CTD PMID:16782764 phencyclidine affects metabolic processing ISO RGD:1346751 6480464 CYP2B6 protein affects the metabolism of Phencyclidine analog CTD PMID:16782764 Phenelzine decreases activity ISO RGD:1346751 6480464 Phenelzine results in decreased activity of CYP2B6 protein CTD PMID:25656918 Phenelzine multiple interactions ISO RGD:1346751 6480464 Phenelzine inhibits the reaction [CYP2B6 protein results in increased hydroxylation of Bupropion] CTD PMID:25656918 phenobarbital multiple interactions ISO RGD:1624098 6480464 Berberine promotes the reaction [Phenobarbital results in increased expression of CYP2B9 mRNA], NR1I3 protein affects the reaction [Phenobarbital results in increased expression of CYP2B9 mRNA] CTD PMID:19482888 , PMID:22342832 phenobarbital decreases expression ISO RGD:1624098 6480464 Phenobarbital results in decreased expression of CYP2B9 protein CTD PMID:35881160 phenobarbital affects localization ISO RGD:1346751 6480464 Phenobarbital affects the localization of CYP2B6 protein CTD PMID:24878338 phenobarbital increases activity ISO RGD:1346751 6480464 Phenobarbital results in increased activity of CYP2B6 protein CTD PMID:14977870 more ... phenobarbital increases expression ISO RGD:1624098 6480464 Phenobarbital results in increased expression of CYP2B9 mRNA CTD PMID:14570766 more ... phenobarbital multiple interactions ISO RGD:1346751 6480464 [Celsior co-treated with Phenobarbital] results in increased expression of CYP2B6 mRNA more ... CTD PMID:10037683 more ... phenobarbital increases expression ISO RGD:1346751 6480464 Phenobarbital results in increased expression of CYP2B10 mRNA more ... CTD PMID:12571232 more ... phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of CYP2B3 mRNA CTD PMID:11328961 , PMID:19162173 phenthoate decreases activity ISO RGD:1346751 6480464 phenthoate results in decreased activity of CYP2B6 protein CTD PMID:22310298 phenthoate increases expression ISO RGD:1346751 6480464 phenthoate results in increased expression of CYP2B6 mRNA CTD PMID:22310298 phenytoin increases expression ISO RGD:1624098 6480464 Phenytoin results in increased expression of CYP2B9 protein CTD PMID:19226368 , PMID:19903449 phenytoin increases activity ISO RGD:1346751 6480464 Phenytoin results in increased activity of CYP2B6 protein CTD PMID:14977870 phenytoin increases expression ISO RGD:1346751 6480464 Phenytoin results in increased expression of CYP2B6 mRNA, Phenytoin results in increased expression of CYP2B6 protein CTD PMID:12571232 more ... phenytoin multiple interactions ISO RGD:1346751 6480464 [Phenytoin results in increased activity of NR1I3 protein alternative form] which results in increased expression of CYP2B6 mRNA more ... CTD PMID:12695351 more ... phenytoin multiple interactions ISO RGD:1624098 6480464 [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of CYP2B9 mRNA CTD PMID:21224054 phosphorus atom multiple interactions ISO RGD:1346751 6480464 [Phosphorus co-treated with paricalcitol] results in decreased expression of CYP2B6 mRNA CTD PMID:17715259 phosphorus(.) multiple interactions ISO RGD:1346751 6480464 [Phosphorus co-treated with paricalcitol] results in decreased expression of CYP2B6 mRNA CTD PMID:17715259 physcion increases hydroxylation ISO RGD:1346751 6480464 CYP2B6 protein results in increased hydroxylation of physcione CTD PMID:29667811 piclamilast increases metabolic processing ISO RGD:1346751 6480464 CYP2B6 protein results in increased metabolism of piclamilast CTD PMID:12464242 pimecrolimus increases expression ISO RGD:1346751 6480464 pimecrolimus results in increased expression of CYP2B6 mRNA CTD PMID:29356861 pioglitazone increases expression ISO RGD:1346751 6480464 pioglitazone results in increased expression of CYP2B6 protein CTD PMID:12642470 piperonyl butoxide multiple interactions ISO RGD:1624098 6480464 [Diethylnitrosamine co-treated with Piperonyl Butoxide] results in increased expression of CYP2B9 mRNA CTD PMID:19690152 piperonyl butoxide increases expression ISO RGD:1624098 6480464 Piperonyl Butoxide results in increased expression of CYP2B9 mRNA CTD PMID:17014948 , PMID:19690152 pirinixic acid affects expression EXP 6480464 pirinixic acid affects the expression of CYP2B3 mRNA CTD PMID:19483382 pirinixic acid increases expression ISO RGD:1346751 6480464 pirinixic acid results in increased expression of CYP2B6 mRNA CTD PMID:27551952 pirinixic acid multiple interactions ISO RGD:1346751 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CYP2B6 mRNA CTD PMID:19710929 pirinixic acid increases expression ISO RGD:1624098 6480464 pirinixic acid results in increased expression of CYP2B9 mRNA CTD PMID:11798191 more ... PK-11195 increases expression ISO RGD:1346751 6480464 PK 11195 results in increased expression of CYP2B6 mRNA CTD PMID:21315811 potassium dichromate increases expression ISO RGD:1624098 6480464 Potassium Dichromate results in increased expression of CYP2B9 mRNA CTD PMID:23608068 pregnenolone 16alpha-carbonitrile decreases expression EXP 6480464 Pregnenolone Carbonitrile results in decreased expression of CYP2B3 mRNA CTD PMID:19162173 pregnenolone 16alpha-carbonitrile decreases expression ISO RGD:1624098 6480464 Pregnenolone Carbonitrile results in decreased expression of CYP2B9 mRNA CTD PMID:27413110 , PMID:28903501 pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of CYP2B3 mRNA CTD PMID:15596064 primaquine multiple interactions ISO RGD:1346751 6480464 [CYP2B6 protein results in increased expression of HBG2 protein] which affects the susceptibility to Primaquine CTD PMID:19616568 primaquine increases metabolic processing ISO RGD:1346751 6480464 CYP2B6 protein results in increased metabolism of Primaquine CTD PMID:19616568 prochloraz multiple interactions ISO RGD:1346751 6480464 [NR1I2 protein co-treated with NR1I3 protein] affects the reaction [prochloraz results in increased expression of CYP2B10 protein] CTD PMID:28058446 prochloraz increases expression ISO RGD:1346751 6480464 prochloraz results in increased expression of CYP2B6 mRNA, prochloraz results in increased expression of CYP2B6 protein CTD PMID:28058446 , PMID:33150952 profenofos increases expression ISO RGD:1346751 6480464 profenofos results in increased expression of CYP2B6 mRNA CTD PMID:22310298 profenofos multiple interactions ISO RGD:1346751 6480464 [CYP2B6 protein results in increased metabolism of profenofos] which results in increased abundance of 4-bromo-2-chlorophenol CTD PMID:23415833 profenofos increases metabolic processing ISO RGD:1346751 6480464 CYP2B6 protein results in increased metabolism of profenofos CTD PMID:23415833 profenofos decreases activity ISO RGD:1346751 6480464 profenofos results in decreased activity of CYP2B6 protein CTD PMID:22310298 progesterone increases expression ISO RGD:1624098 6480464 Progesterone results in increased expression of CYP2B9 mRNA CTD PMID:7771797 progesterone multiple interactions ISO RGD:1346751 6480464 [Progesterone co-treated with Estradiol] inhibits the reaction [6-(4-chlorophenyl)imidazo(2 more ... CTD PMID:21768169 progesterone increases expression ISO RGD:1346751 6480464 Progesterone results in increased expression of CYP2B6 mRNA CTD PMID:22837389 propiconazole increases expression ISO RGD:1624098 6480464 propiconazole results in increased expression of CYP2B9 mRNA CTD PMID:22334560 , PMID:23970803 propiconazole increases expression ISO RGD:1346751 6480464 propiconazole results in increased expression of CYP2B6 mRNA CTD PMID:30293151 , PMID:33575850 propiconazole multiple interactions ISO RGD:1346751 6480464 [propiconazole co-treated with fludioxonil] results in increased expression of CYP2B6 mRNA CTD PMID:33575850 propiconazole affects expression EXP 6480464 propiconazole affects the expression of CYP2B3 mRNA CTD PMID:17383973 propofol increases metabolic processing ISO RGD:1346751 6480464 CYP2B6 protein results in increased metabolism of Propofol CTD PMID:15769884 pterostilbene increases expression ISO RGD:1346751 6480464 pterostilbene results in increased expression of CYP2B6 mRNA CTD PMID:30394306 pyrene multiple interactions ISO RGD:1346751 6480464 [fluoranthene co-treated with Benzo(a)pyrene] inhibits the reaction [pyrene results in increased expression of CYP2B6 mRNA] more ... CTD PMID:26160115 , PMID:33249052 pyrene increases expression ISO RGD:1346751 6480464 pyrene results in increased expression of CYP2B6 mRNA CTD PMID:26160115 , PMID:33249052 pyrethrins increases expression ISO RGD:1346751 6480464 Pyrethrins results in increased expression of CYP2B6 mRNA CTD PMID:18022748 quercetin multiple interactions ISO RGD:1624098 6480464 [Dietary Fats co-treated with Quercetin] affects the expression of CYP2B9 mRNA CTD PMID:25047408 reserpine multiple interactions ISO RGD:1346751 6480464 [Reserpine results in increased activity of NR1I3 protein alternative form] which results in increased expression of CYP2B6 mRNA CTD PMID:17041008 resveratrol multiple interactions ISO RGD:1624098 6480464 Resveratrol inhibits the reaction [Dietary Fats affects the expression of CYP2B9 mRNA], Resveratrol inhibits the reaction [titanium dioxide results in increased expression of CYP2B9 mRNA] CTD PMID:17086191 , PMID:31298478 rifampicin multiple interactions ISO RGD:1346751 6480464 [Rifampin co-treated with Monocrotophos] results in increased activity of CYP2B6 protein more ... CTD PMID:12695351 more ... rifampicin decreases expression ISO RGD:1624098 6480464 Rifampin results in decreased expression of CYP2B9 mRNA CTD PMID:30503582 rifampicin increases activity ISO RGD:1346751 6480464 Rifampin results in increased activity of CYP2B6 protein CTD PMID:14977870 more ... rifampicin multiple interactions ISO RGD:1624098 6480464 [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of CYP2B9 mRNA CTD PMID:21224054 rifampicin increases expression ISO RGD:1346751 6480464 Rifampin results in increased expression of CYP2B6 mRNA, Rifampin results in increased expression of CYP2B6 protein CTD PMID:12040753 more ... ritonavir increases activity ISO RGD:1346751 6480464 Ritonavir results in increased activity of CYP2B6 protein CTD PMID:26626330 ritonavir increases expression ISO RGD:1346751 6480464 Ritonavir results in increased expression of CYP2B6 protein CTD PMID:14977870 romidepsin affects metabolic processing ISO RGD:1346751 6480464 CYP2B6 protein affects the metabolism of romidepsin CTD PMID:15635176 selenium atom increases expression ISO RGD:1624098 6480464 Selenium deficiency results in increased expression of CYP2B9 mRNA CTD PMID:16170372 senecionine increases expression ISO RGD:1346751 6480464 senecionine results in increased expression of CYP2B6 mRNA CTD PMID:26100227 sertraline multiple interactions ISO RGD:1346751 6480464 [Sertraline results in decreased activity of CYP2B6 protein] which results in decreased metabolism of Bupropion, CYP2B6 protein results in decreased methylation of and results in increased metabolism of Sertraline CTD PMID:15547048 , PMID:26599973 sertraline decreases activity ISO RGD:1346751 6480464 Sertraline results in decreased activity of CYP2B6 protein CTD PMID:26599973 Shikonin decreases activity ISO RGD:1346751 6480464 shikonin results in decreased activity of CYP2B6 protein CTD PMID:28941798 sibutramine decreases activity ISO RGD:1346751 6480464 sibutramine results in decreased activity of CYP2B6 protein CTD PMID:23777987 sibutramine multiple interactions ISO RGD:1346751 6480464 sibutramine inhibits the reaction [CYP2B6 protein results in increased hydroxylation of Bupropion] CTD PMID:23777987 simvastatin increases expression ISO RGD:1346751 6480464 Simvastatin results in increased expression of CYP2B6 mRNA CTD PMID:15802384 sirolimus increases expression ISO RGD:1346751 6480464 Sirolimus results in increased expression of CYP2B6 mRNA CTD PMID:25929522 sodium arsenite affects expression ISO RGD:1624098 6480464 sodium arsenite affects the expression of CYP2B9 mRNA CTD PMID:16507464 sodium arsenite decreases expression ISO RGD:1346751 6480464 sodium arsenite results in decreased expression of CYP2B6 mRNA CTD PMID:29301061 sodium arsenite affects methylation ISO RGD:1346751 6480464 sodium arsenite affects the methylation of CYP2B6 gene CTD PMID:28589171 sodium arsenite decreases expression ISO RGD:1624098 6480464 sodium arsenite results in decreased expression of CYP2B9 mRNA CTD PMID:11353140 , PMID:17350061 sodium arsenite increases expression ISO RGD:1624098 6480464 sodium arsenite results in increased expression of CYP2B9 mRNA CTD PMID:25065748 sodium dichromate affects expression EXP 6480464 sodium bichromate affects the expression of CYP2B3 mRNA CTD PMID:22110744 steviol increases expression ISO RGD:1346751 6480464 steviol results in increased expression of CYP2B6 mRNA CTD PMID:28887089 streptozocin multiple interactions ISO RGD:1624098 6480464 [Streptozocin co-treated with Dietary Fats] results in increased expression of CYP2B9 mRNA more ... CTD PMID:22342832 , PMID:29127188 streptozocin increases expression ISO RGD:1624098 6480464 Streptozocin results in increased expression of CYP2B9 mRNA CTD PMID:22342832 Sudan I multiple interactions ISO RGD:1346751 6480464 CYB5A protein inhibits the reaction [CYP2B6 protein results in increased oxidation of 1-phenylazo-2-naphthol] CTD PMID:17159775 Sudan I increases oxidation ISO RGD:1346751 6480464 CYP2B6 protein results in increased oxidation of 1-phenylazo-2-naphthol CTD PMID:17159775 sulconazole increases expression ISO RGD:1346751 6480464 sulconazole results in increased expression of CYP2B6 mRNA CTD PMID:31312845 sulconazole multiple interactions ISO RGD:1346751 6480464 [sulconazole co-treated with NR1I3 protein alternative form] results in increased expression of CYP2B6 mRNA, [sulconazole co-treated with NR1I3 protein mutant form] results in increased expression of CYP2B6 mRNA CTD PMID:31312845 sulfinpyrazone increases expression ISO RGD:1346751 6480464 Sulfinpyrazone results in increased expression of CYP2B6 protein CTD PMID:14977870 sulfluramid increases expression ISO RGD:1346751 6480464 sulfluramid results in increased expression of CYP2B6 mRNA CTD PMID:35337807 tamoxifen increases expression ISO RGD:1624098 6480464 Tamoxifen results in increased expression of CYP2B9 mRNA CTD PMID:7771797 tamoxifen increases metabolic processing ISO RGD:1346751 6480464 CYP2B6 protein results in increased metabolism of Tamoxifen CTD PMID:29285606 tamoxifen multiple interactions ISO RGD:1346751 6480464 [CYP2B6 protein results in increased metabolism of Tamoxifen] which results in increased abundance of 1-(4-hydroxyphenyl)-1, 2-diphenyl-1-butene CTD PMID:29285606 tamoxifen increases activity ISO RGD:1346751 6480464 Tamoxifen metabolite results in increased activity of CYP2B6 protein CTD PMID:29285606 tamoxifen increases expression ISO RGD:1346751 6480464 Tamoxifen results in increased expression of CYP2B6 protein CTD PMID:19812351 tartrazine multiple interactions ISO RGD:1346751 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of CYP2B6 mRNA CTD PMID:33819548 tauroursodeoxycholic acid decreases expression EXP 6480464 ursodoxicoltaurine results in decreased expression of CYP2B3 mRNA CTD PMID:15885361 tebuconazole multiple interactions ISO RGD:1346751 6480464 [tebuconazole co-treated with fludioxonil] results in increased expression of CYP2B6 mRNA CTD PMID:33575850 tebuconazole increases expression ISO RGD:1346751 6480464 tebuconazole results in increased expression of CYP2B6 mRNA CTD PMID:30458266 , PMID:33575850 tebufenozide increases expression ISO RGD:1346751 6480464 tebufenozide results in increased expression of CYP2B6 mRNA CTD PMID:22310298 teriflunomide increases activity ISO RGD:1346751 6480464 teriflunomide results in increased activity of CYP2B6 protein CTD PMID:30364229 teriflunomide increases expression ISO RGD:1346751 6480464 teriflunomide results in increased expression of CYP2B6 mRNA CTD PMID:30364229 tert-butanol increases expression ISO RGD:1624098 6480464 tert-Butyl Alcohol results in increased expression of CYP2B9 mRNA CTD PMID:19760798 testosterone decreases expression ISO RGD:1624098 6480464 Testosterone results in decreased expression of CYP2B9 mRNA CTD PMID:20844152 , PMID:21669218 testosterone increases hydroxylation ISO RGD:1346751 6480464 CYP2B6 protein results in increased hydroxylation of Testosterone CTD PMID:19833192 testosterone increases metabolic processing ISO RGD:1346751 6480464 CYP2B6 protein results in increased metabolism of Testosterone CTD PMID:12464242 testosterone affects expression ISO RGD:1624098 6480464 Testosterone affects the expression of CYP2B9 mRNA CTD PMID:7771797 Testosterone propionate affects expression ISO RGD:1624098 6480464 Testosterone Propionate affects the expression of CYP2B9 CTD PMID:20943812 tetrachloroethene increases metabolic processing ISO RGD:1346751 6480464 CYP2B6 protein results in increased metabolism of Tetrachloroethylene CTD PMID:11684365 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of CYP2B3 mRNA, Carbon Tetrachloride results in decreased expression of CYP2B3 protein CTD PMID:17606319 , PMID:31150632 tetrachloromethane increases expression ISO RGD:1624098 6480464 Carbon Tetrachloride results in increased expression of CYP2B9 mRNA CTD PMID:29987408 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of CYP2B3 mRNA] CTD PMID:31150632 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of CYP2B3 mRNA CTD PMID:12734012 tetrahydrocurcumin decreases expression ISO RGD:1624098 6480464 tetrahydrocurcumin results in decreased expression of CYP2B9 mRNA CTD PMID:26102010 thalidomide increases expression ISO RGD:1346751 6480464 Thalidomide results in increased expression of CYP2B6 mRNA CTD PMID:24460184 , PMID:28496040 thiabendazole increases expression ISO RGD:1346751 6480464 Thiabendazole results in increased expression of CYP2B6 mRNA CTD PMID:18570159 thiacloprid multiple interactions ISO RGD:1624098 6480464 [Dietary Fats co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Captan co-treated with Chlorpyrifos co-treated with thiacloprid co-treated with Thiophanate co-treated with Ziram] results in increased expression of CYP2B9 mRNA CTD PMID:32745781 thiacloprid multiple interactions ISO RGD:1346751 6480464 [clothianidin co-treated with thiacloprid] results in increased expression of CYP2B6 protein more ... CTD PMID:32201337 thiacloprid increases expression ISO RGD:1346751 6480464 thiacloprid results in increased expression of CYP2B6 mRNA CTD PMID:32201337 thioacetamide affects expression EXP 6480464 Thioacetamide affects the expression of CYP2B3 mRNA CTD PMID:19483382 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of CYP2B3 mRNA CTD PMID:34492290 thiophanate-methyl multiple interactions ISO RGD:1624098 6480464 [Dietary Fats co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Captan co-treated with Chlorpyrifos co-treated with thiacloprid co-treated with Thiophanate co-treated with Ziram] results in increased expression of CYP2B9 mRNA CTD PMID:32745781 Thiotepa affects response to substance ISO RGD:1346751 6480464 CYP2B6 protein affects the susceptibility to Thiotepa CTD PMID:19076156 Thiotepa affects export ISO RGD:1346751 6480464 CYP2B6 gene SNP affects the export of Thiotepa CTD PMID:19076156 Thiotepa decreases activity ISO RGD:1346751 6480464 Thiotepa results in decreased activity of CYP2B6 protein CTD PMID:15769884 Thiotepa multiple interactions ISO RGD:1346751 6480464 Thiotepa inhibits the reaction [CYP2B6 protein results in increased hydrolysis of Bupropion], Thiotepa inhibits the reaction [CYP2B6 protein results in increased hydroxylation of Bupropion] CTD PMID:18611395 , PMID:23777987 ticlopidine multiple interactions ISO RGD:1346751 6480464 Ticlopidine binds to and results in decreased activity of CYP2B6 protein more ... CTD PMID:16855053 more ... ticlopidine decreases activity ISO RGD:1346751 6480464 Ticlopidine results in decreased activity of CYP2B6 protein CTD PMID:19328226 more ... tienilic acid decreases activity ISO RGD:1346751 6480464 Ticrynafen results in decreased activity of CYP2B6 protein CTD PMID:21915887 tienilic acid multiple interactions ISO RGD:1346751 6480464 Ticrynafen inhibits the reaction [CYP2B6 protein results in increased chemical synthesis of hydroxybupropion], Ticrynafen inhibits the reaction [CYP2B6 protein results in increased metabolism of Bupropion] CTD PMID:21915887 tirapazamine multiple interactions ISO RGD:1346751 6480464 POR protein promotes the reaction [CYP2B6 protein results in increased susceptibility to tirapazamine] CTD PMID:10919648 titanium dioxide decreases expression ISO RGD:1624098 6480464 titanium dioxide results in decreased expression of CYP2B9 mRNA CTD PMID:23557971 titanium dioxide multiple interactions ISO RGD:1624098 6480464 Resveratrol inhibits the reaction [titanium dioxide results in increased expression of CYP2B9 mRNA] CTD PMID:31298478 titanium dioxide increases expression ISO RGD:1624098 6480464 titanium dioxide results in increased expression of CYP2B9 mRNA CTD PMID:31298478 , PMID:31769605 toxaphene increases expression ISO RGD:1624098 6480464 Toxaphene results in increased expression of CYP2B9 mRNA CTD PMID:28218408 toxaphene multiple interactions ISO RGD:1624098 6480464 NR1I3 gene mutant form inhibits the reaction [Toxaphene results in increased expression of CYP2B9 mRNA] CTD PMID:28218408 tranylcypromine multiple interactions ISO RGD:1346751 6480464 Tranylcypromine inhibits the reaction [[CYP2B6 protein results in increased metabolism of 7-ethoxy-4-trifluoromethylcoumarin] which results in increased chemical synthesis of 7-hydroxy-4-trifluoromethylcoumarin], Tranylcypromine inhibits the reaction [CYP2B6 protein results in increased metabolism of Bupropion] CTD PMID:23850985 , PMID:28119166 tranylcypromine decreases activity ISO RGD:1346751 6480464 Tranylcypromine results in decreased activity of CYP2B6 protein CTD PMID:23850985 , PMID:28119166 triadimefon affects expression EXP 6480464 triadimefon affects the expression of CYP2B3 mRNA CTD PMID:17383973 triclocarban multiple interactions ISO RGD:1346751 6480464 ESR1 protein affects the reaction [triclocarban results in increased expression of CYP2B6 mRNA] CTD PMID:22761658 triclocarban increases expression ISO RGD:1346751 6480464 triclocarban results in increased expression of CYP2B6 mRNA CTD PMID:22761658 triclosan increases expression ISO RGD:1346751 6480464 Triclosan results in increased expression of CYP2B6 mRNA CTD PMID:29849464 triclosan multiple interactions ISO RGD:1346751 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Triclosan] results in decreased expression of CYP2B6 mRNA CTD PMID:33819548 triflumuron increases metabolic processing ISO RGD:1346751 6480464 CYP2B6 protein results in increased metabolism of triflumuron CTD PMID:31082524 trifluralin multiple interactions ISO RGD:1346751 6480464 CYP2B6 protein results in increased metabolism of and results in decreased susceptibility to Trifluralin CTD PMID:15853388 Tris(1-aziridinyl)phosphine oxide affects export ISO RGD:1346751 6480464 CYP2B6 gene SNP affects the export of Triethylenephosphoramide CTD PMID:19076156 Tris(1-aziridinyl)phosphine oxide affects response to substance ISO RGD:1346751 6480464 CYP2B6 protein affects the susceptibility to Triethylenephosphoramide CTD PMID:19076156 troglitazone multiple interactions ISO RGD:1346751 6480464 [Oleic Acid co-treated with Troglitazone] results in increased expression of CYP2B6 mRNA, [Troglitazone results in increased activity of NR1I3 protein alternative form] which results in increased expression of CYP2B6 mRNA CTD PMID:17041008 , PMID:24534255 troglitazone increases expression ISO RGD:1346751 6480464 troglitazone results in increased expression of CYP2B6 mRNA, troglitazone results in increased expression of CYP2B6 protein CTD PMID:10752642 more ... tryptamines multiple interactions ISO RGD:1346751 6480464 [Tryptamines analog results in decreased activity of CYP2B6 protein] which results in decreased metabolism of Bupropion CTD PMID:26599973 tryptamines decreases activity ISO RGD:1346751 6480464 Tryptamines analog results in decreased activity of CYP2B6 protein CTD PMID:26599973 ursodeoxycholic acid decreases expression EXP 6480464 Ursodeoxycholic Acid results in decreased expression of CYP2B3 mRNA CTD PMID:15885361 valproic acid affects expression ISO RGD:1624098 6480464 Valproic Acid affects the expression of CYP2B9 mRNA CTD PMID:17963808 valproic acid decreases methylation ISO RGD:1346751 6480464 Valproic Acid results in decreased methylation of CYP2B6 gene CTD PMID:29501571 valproic acid increases response to substance ISO RGD:1346751 6480464 CYP2B6 protein results in increased susceptibility to Valproic Acid CTD PMID:28762043 valproic acid increases expression ISO RGD:1346751 6480464 Valproic Acid results in increased expression of CYP2B6 mRNA CTD PMID:29154799 , PMID:29501571 valproic acid increases expression ISO RGD:1624098 6480464 Valproic Acid results in increased expression of CYP2B9 mRNA CTD PMID:24489787 valproic acid increases metabolic processing ISO RGD:1346751 6480464 CYP2B6 protein results in increased metabolism of Valproic Acid CTD PMID:16945988 vatalanib multiple interactions ISO RGD:1346751 6480464 [vatalanib co-treated with NR1I3 protein alternative form] results in increased expression of CYP2B6 mRNA CTD PMID:31312845 ziram multiple interactions ISO RGD:1624098 6480464 [Dietary Fats co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Captan co-treated with Chlorpyrifos co-treated with thiacloprid co-treated with Thiophanate co-treated with Ziram] results in increased expression of CYP2B9 mRNA CTD PMID:32745781
